{"results":[{"start_date":"2011-01-01","end_date":"2011-03-31","filing_date":"2011-05-06","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2011","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-11-004721","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-11-004721/files/vrtx-20110331.xml","financials":{"balance_sheet":{"equity_attributable_to_parent":{"value":391672000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"long_term_debt":{"value":105000000.0,"unit":"USD","label":"Long-term Debt","order":810},"liabilities_and_equity":{"value":1538487000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_liabilities":{"value":381314000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity":{"value":391672000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":665513000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":855158000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_liabilities":{"value":625620000.0,"unit":"USD","label":"Other Non-current Liabilities","order":820},"assets":{"value":1538487000.0,"unit":"USD","label":"Assets","order":100},"current_liabilities":{"value":416195000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":872974000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":70877000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":594636000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":730620000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":1146815000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":17816000.0,"unit":"USD","label":"Inventory","order":230},"accounts_payable":{"value":34881000.0,"unit":"USD","label":"Accounts Payable","order":710}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_after_tax":{"value":-176096000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss":{"value":-176096000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":233561000.0,"unit":"USD","label":"Costs And Expenses","order":600},"benefits_costs_expenses":{"value":249758000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":202329000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_average_shares":{"value":202329000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit":{"value":0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":-0.87,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"revenues":{"value":73662000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":-159899000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"interest_expense_operating":{"value":12001000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":-176096000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_parent":{"value":-176096000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_earnings_per_share":{"value":-0.87,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_before_equity_method_investments":{"value":-176096000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"other_operating_expenses":{"value":3426000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"selling_general_and_administrative_expenses":{"value":71523000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_available_to_common_stockholders_basic":{"value":-176096000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":158612000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":0,"unit":"USD","label":"Cost Of Revenue","order":300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue_goods":{"value":0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"gross_profit":{"value":73662000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_expenses":{"value":233561000.0,"unit":"USD","label":"Operating Expenses","order":1000}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-176096000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-175662000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":-186628000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":405952000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":372000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":405952000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-16357000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":-186628000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":202967000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":-16357000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":203339000.0,"unit":"USD","label":"Net Cash Flow","order":1100}}}},{"start_date":"2011-04-01","end_date":"2011-06-30","filing_date":"2011-08-09","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2011","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-11-007153","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-11-007153/files/vrtx-20110630.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":55030000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":11659000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":11625000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":34000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":55030000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":172790000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":172790000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":-216195000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":-216195000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_after_tax":{"value":-199318000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":-174069000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_average_shares":{"value":204413000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_expenses":{"value":274910000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_tax_expense_benefit":{"value":24448000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-25249000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_attributable_to_parent":{"value":-174069000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_average_shares":{"value":204413000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"selling_general_and_administrative_expenses":{"value":96663000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":-165890000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":4643000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"cost_of_revenue":{"value":5404000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss":{"value":-199318000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"revenues":{"value":114424000.0,"unit":"USD","label":"Revenues","order":100},"cost_of_revenue_goods":{"value":5404000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"basic_earnings_per_share":{"value":-0.85,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":-174870000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"research_and_development":{"value":173604000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_before_equity_method_investments":{"value":-174870000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"benefits_costs_expenses":{"value":289294000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_expense_operating":{"value":6962000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"gross_profit":{"value":109020000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_earnings_per_share":{"value":-0.85,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"costs_and_expenses":{"value":280314000.0,"unit":"USD","label":"Costs And Expenses","order":600}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-25249000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-199392000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-174143000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"noncurrent_liabilities":{"value":834952000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities_and_equity":{"value":1763100000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"accounts_payable":{"value":67275000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_noncontrolling_interest":{"value":105332000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_assets":{"value":935976000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":52622000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":307549000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"fixed_assets":{"value":84203000.0,"unit":"USD","label":"Fixed Assets","order":320},"long_term_debt":{"value":105000000.0,"unit":"USD","label":"Long-term Debt","order":810},"other_noncurrent_liabilities":{"value":729952000.0,"unit":"USD","label":"Other Non-current Liabilities","order":820},"current_liabilities":{"value":478968000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":1313920000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":412881000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":411693000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_assets":{"value":827124000.0,"unit":"USD","label":"Current Assets","order":200},"other_noncurrent_assets":{"value":851773000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":774502000.0,"unit":"USD","label":"Other Current Assets","order":250},"assets":{"value":1763100000.0,"unit":"USD","label":"Assets","order":100}}}},{"start_date":"2011-07-01","end_date":"2011-09-30","filing_date":"2011-11-03","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2011","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-11-009007","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-11-009007/files/vrtx-20110930.xml","financials":{"income_statement":{"income_loss_before_equity_method_investments":{"value":200610000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":215707000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue_goods":{"value":35285000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":408208000.0,"unit":"USD","label":"Operating Expenses","order":1000},"other_operating_expenses":{"value":108502000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"revenues":{"value":659200000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":218974000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue":{"value":35285000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":7342000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":443493000.0,"unit":"USD","label":"Costs And Expenses","order":600},"gross_profit":{"value":623915000.0,"unit":"USD","label":"Gross Profit","order":800},"income_loss_from_continuing_operations_before_tax":{"value":200610000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss":{"value":228452000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":219349000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":-27842000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"benefits_costs_expenses":{"value":458590000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_parent":{"value":221110000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":206002000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"interest_expense_operating":{"value":7059000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"research_and_development":{"value":189052000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_earnings_per_share":{"value":1.06,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_after_tax":{"value":228452000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_earnings_per_share":{"value":1.02,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":110654000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010}},"balance_sheet":{"accounts_payable":{"value":49248000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":812203000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":579762000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":694150000.0,"unit":"USD","label":"Equity","order":1400},"inventory":{"value":67654000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":548949000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":2091998000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"long_term_debt":{"value":105000000.0,"unit":"USD","label":"Long-term Debt","order":810},"other_noncurrent_liabilities":{"value":707203000.0,"unit":"USD","label":"Other Non-current Liabilities","order":820},"fixed_assets":{"value":101268000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_assets":{"value":1178171000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":744905000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":499701000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":846173000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":1245825000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":2091998000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":114388000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":1361152000.0,"unit":"USD","label":"Liabilities","order":600}},"cash_flow_statement":{"net_cash_flow_continuing":{"value":84756000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":-60000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":42895000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":21446000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":20069000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":42895000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":21446000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":84696000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":20069000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":7342000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":-238000,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":228452000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":220872000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2011-01-01","end_date":"2011-12-31","filing_date":"2012-02-22","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2011","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-12-001298","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-12-001298/files/vrtx-20111231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-124238000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":143735000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":212412000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":143735000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":212412000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-124238000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":214000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow":{"value":232337000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":232123000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"assets":{"value":2204280000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":846420000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"wages":{"value":57453000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_parent":{"value":786843000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":873026000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":74642000.0,"unit":"USD","label":"Accounts Payable","order":710},"inventory":{"value":112430000.0,"unit":"USD","label":"Inventory","order":230},"current_assets":{"value":1331254000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":260253000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_noncontrolling_interest":{"value":141633000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_liabilities":{"value":392348000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":2204280000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":1238768000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":1218824000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":739850000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":928476000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":133176000.0,"unit":"USD","label":"Fixed Assets","order":320}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":41193000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":14000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":41193000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"diluted_earnings_per_share":{"value":0.14,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":400721000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"other_operating_expenses":{"value":124754000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_expenses":{"value":1233181000.0,"unit":"USD","label":"Operating Expenses","order":1000},"cost_of_revenue":{"value":63625000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"benefits_costs_expenses":{"value":1350181000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":291000,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"interest_expense_operating":{"value":38452000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"research_and_development":{"value":707706000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_from_continuing_operations_after_tax":{"value":41179000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_average_shares":{"value":204891000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_parent":{"value":29574000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_average_shares":{"value":208807000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_before_tax":{"value":60445000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss":{"value":41179000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":1296806000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":11605000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit_deferred":{"value":-11103000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_tax_expense_benefit_current":{"value":30369000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"revenues":{"value":1410626000.0,"unit":"USD","label":"Revenues","order":100},"basic_earnings_per_share":{"value":0.14,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue_goods":{"value":63625000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_before_equity_method_investments":{"value":60445000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"gross_profit":{"value":1347001000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_available_to_common_stockholders_basic":{"value":29283000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":291000,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_tax_expense_benefit":{"value":19266000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_income_loss":{"value":113820000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}}}},{"start_date":"2012-01-01","end_date":"2012-03-31","filing_date":"2012-05-10","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2012","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-12-005755","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-12-005755/files/vrtx-20120331.xml","financials":{"balance_sheet":{"other_noncurrent_assets":{"value":739398000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":909729000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":1306519000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":170331000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":137583000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":2345843000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":883451000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":73226000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities_and_equity":{"value":2345843000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_liabilities":{"value":283589000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity":{"value":1068081000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_parent":{"value":930498000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":356815000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":1436114000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":129595000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":1240266000.0,"unit":"USD","label":"Liabilities","order":600}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":21525000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-207397000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":-136000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow":{"value":-207533000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-231702000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":2916000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":2916000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":21525000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-231702000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"income_statement":{"interest_expense_operating":{"value":4105000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"benefits_costs_expenses":{"value":350829000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"cost_of_revenue_goods":{"value":25918000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-3714000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_earnings_per_share":{"value":0.44,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":87908000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_expenses":{"value":321170000.0,"unit":"USD","label":"Operating Expenses","order":1000},"revenues":{"value":438737000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit":{"value":32000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"research_and_development":{"value":196371000.0,"unit":"USD","label":"Research and Development","order":1030},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_earnings_per_share":{"value":0.43,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":87876000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":111146000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":91649000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_before_equity_method_investments":{"value":87908000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"costs_and_expenses":{"value":347088000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_after_tax":{"value":87876000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_average_shares":{"value":219264000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":91590000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue":{"value":25918000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"basic_average_shares":{"value":208018000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_available_to_common_stockholders_basic":{"value":90684000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"other_operating_expenses":{"value":13653000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"gross_profit":{"value":412819000.0,"unit":"USD","label":"Gross Profit","order":800}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-3714000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":88301000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":92015000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2012-04-01","end_date":"2012-06-30","filing_date":"2012-08-08","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2012","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-12-007979","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-12-007979/files/vrtx-20120630.xml","financials":{"balance_sheet":{"accounts_payable":{"value":59352000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_assets":{"value":1011551000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":87805000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":981539000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":1361249000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":167920000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities_and_equity":{"value":2604856000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":272561000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":320358000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":2604856000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":1205693000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":738990000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":1593305000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":379710000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":1505500000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_parent":{"value":1037773000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-64976000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-34513000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":30463000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"revenues":{"value":418305000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":117514000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":313756000.0,"unit":"USD","label":"Gross Profit","order":800},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_income_loss":{"value":-10770000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":-0.31,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":30463000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":196544000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_expenses":{"value":324526000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":-14405000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"other_operating_expenses":{"value":10468000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit":{"value":20063000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_average_shares":{"value":211344000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"diluted_earnings_per_share":{"value":-0.31,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":-34468000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_parent":{"value":-64931000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"interest_expense_operating":{"value":4195000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":-14405000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_from_continuing_operations_after_tax":{"value":-34468000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"benefits_costs_expenses":{"value":432710000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":211344000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue_goods":{"value":104549000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"cost_of_revenue":{"value":104549000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_available_to_common_stockholders_basic":{"value":-64931000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"costs_and_expenses":{"value":429075000.0,"unit":"USD","label":"Costs And Expenses","order":600}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":118405000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":186222000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"exchange_gains_losses":{"value":84000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-70043000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":186138000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-70043000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":137692000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":137692000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":118405000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}}}},{"start_date":"2012-07-01","end_date":"2012-09-30","filing_date":"2012-11-06","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2012","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001047469-12-010125","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001047469-12-010125/files/vrtx-20120930.xml","financials":{"income_statement":{"operating_expenses":{"value":306397000.0,"unit":"USD","label":"Operating Expenses","order":1000},"benefits_costs_expenses":{"value":341118000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":-57543000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":200161000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_noncontrolling_interest":{"value":31076000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_before_tax":{"value":-5112000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"costs_and_expenses":{"value":337077000.0,"unit":"USD","label":"Costs And Expenses","order":600},"revenues":{"value":336006000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit":{"value":21355000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"selling_general_and_administrative_expenses":{"value":97684000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"diluted_earnings_per_share":{"value":-0.27,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"cost_of_revenue_goods":{"value":30680000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"basic_earnings_per_share":{"value":-0.27,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"basic_average_shares":{"value":213767000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"gross_profit":{"value":305326000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_income_loss":{"value":-1071000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_before_equity_method_investments":{"value":-5112000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_average_shares":{"value":213767000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"cost_of_revenue":{"value":30680000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":-57543000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":-26467000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_expense_operating":{"value":4560000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_after_tax":{"value":-26467000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"other_operating_expenses":{"value":8552000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900}},"balance_sheet":{"noncurrent_assets":{"value":1084300000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"noncurrent_liabilities":{"value":1047346000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"fixed_assets":{"value":124148000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_parent":{"value":1027733000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":1634523000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_noncontrolling_interest":{"value":198714000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_liabilities":{"value":406731000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":960152000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":1454077000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":2718823000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":86275000.0,"unit":"USD","label":"Inventory","order":230},"other_current_assets":{"value":1548248000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":2718823000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":1226447000.0,"unit":"USD","label":"Equity","order":1400},"accounts_payable":{"value":83732000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":322999000.0,"unit":"USD","label":"Other Current Liabilities","order":740}},"cash_flow_statement":{"net_cash_flow":{"value":-17233000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-131228000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":-58000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-131228000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":-17175000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":8150000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_financing_activities":{"value":8150000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":105961000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":105961000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-57286000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":31076000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-26210000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2012-01-01","end_date":"2012-12-31","filing_date":"2013-03-01","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2012","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-13-000009","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-13-000009/files/vrtx-20121231.xml","financials":{"balance_sheet":{"current_assets":{"value":1589585000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":1559121000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":433609000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":1169703000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":101292000.0,"unit":"USD","label":"Accounts Payable","order":710},"assets":{"value":2759288000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":269192000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":2759288000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":736094000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":999180000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":1195852000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":1092282000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"wages":{"value":62140000.0,"unit":"USD","label":"Wages","order":730},"liabilities":{"value":1524906000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":432624000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":196672000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":30464000.0,"unit":"USD","label":"Inventory","order":230}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":172204000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":267841000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":267841000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":14087000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-425817000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":13946000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"exchange_gains_losses":{"value":-141000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":172204000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-425817000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":503000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-50632000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-106529000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":55897000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"diluted_average_shares":{"value":211946000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"cost_of_revenue_goods":{"value":236742000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_tax_expense_benefit_current":{"value":2094000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"revenues":{"value":1527042000.0,"unit":"USD","label":"Revenues","order":100},"research_and_development":{"value":806185000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss":{"value":-51135000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":44987000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit_deferred":{"value":36660000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"basic_average_shares":{"value":211946000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":-0.5,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":436796000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":1524710000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":38754000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":55897000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_after_tax":{"value":-51135000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_before_equity_method_investments":{"value":-12381000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"interest_expense_operating":{"value":16653000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":-12381000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":236742000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"basic_earnings_per_share":{"value":-0.5,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"gross_profit":{"value":1290300000.0,"unit":"USD","label":"Gross Profit","order":800},"benefits_costs_expenses":{"value":1539423000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_parent":{"value":-107032000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":1287968000.0,"unit":"USD","label":"Operating Expenses","order":1000},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":-107032000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_income_loss":{"value":2332000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}}}},{"start_date":"2013-01-01","end_date":"2013-03-31","filing_date":"2013-05-08","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2013","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-13-000024","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-13-000024/files/vrtx-20130331.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-37596000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-6135000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":-65778000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-6135000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-110308000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":-65778000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-799000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow":{"value":-111107000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-37596000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":-599000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-4611000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-313226000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-308615000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"costs_and_expenses":{"value":766656000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_earnings_per_share":{"value":-1.43,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_expenses":{"value":735701000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":215421000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_parent":{"value":-308016000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss":{"value":-312627000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_before_equity_method_investments":{"value":-442940000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_before_tax":{"value":-442940000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":-1.43,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"research_and_development":{"value":218095000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":30955000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"cost_of_revenue_goods":{"value":30955000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_available_to_common_stockholders_basic":{"value":-308016000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_after_tax":{"value":-312627000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_income_loss":{"value":-438288000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"selling_general_and_administrative_expenses":{"value":92879000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit":{"value":-130313000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"gross_profit":{"value":297413000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":328368000.0,"unit":"USD","label":"Revenues","order":100},"diluted_average_shares":{"value":215421000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"other_operating_expenses":{"value":424727000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"benefits_costs_expenses":{"value":771308000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-4611000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}},"balance_sheet":{"other_noncurrent_assets":{"value":322219000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":1007763000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":1415402000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":407639000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity":{"value":937960000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":1565783000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":2392234000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":504232000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":826451000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":191845000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":21532000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":348012000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_current_assets":{"value":1544251000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_parent":{"value":746115000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":59627000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities_and_equity":{"value":2392234000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}}}},{"start_date":"2013-04-01","end_date":"2013-06-30","filing_date":"2013-08-02","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2013","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-13-000038","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-13-000038/files/vrtx-20130630.xml","financials":{"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"selling_general_and_administrative_expenses":{"value":106521000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit":{"value":-1799000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_before_tax":{"value":-63511000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_expenses":{"value":342988000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-4547000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"revenues":{"value":310750000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_after_tax":{"value":-61712000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"gross_profit":{"value":286055000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_average_shares":{"value":222053000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"other_operating_expenses":{"value":14012000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_parent":{"value":-57165000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss":{"value":-61712000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_income_loss":{"value":-56933000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"benefits_costs_expenses":{"value":374261000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_earnings_per_share":{"value":-0.26,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"costs_and_expenses":{"value":367683000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_before_equity_method_investments":{"value":-63511000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"cost_of_revenue":{"value":24695000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"basic_earnings_per_share":{"value":-0.26,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"research_and_development":{"value":222455000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_available_to_common_stockholders_basic":{"value":-57165000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue_goods":{"value":24695000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"basic_average_shares":{"value":222053000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"balance_sheet":{"fixed_assets":{"value":581738000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_assets":{"value":1716590000.0,"unit":"USD","label":"Current Assets","order":200},"other_noncurrent_assets":{"value":286001000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":1509449000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":381652000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":867739000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":19509000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":1035666000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":2584329000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":186996000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":1697081000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":48570000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":333082000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":2584329000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_parent":{"value":1322453000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":654014000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800}},"cash_flow_statement":{"net_cash_flow":{"value":152426000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-4691000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":157488000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":278000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":157488000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":152148000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-4691000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":-927000,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":-927000,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-4547000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-81000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-57246000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-61793000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2013-07-01","end_date":"2013-09-30","filing_date":"2013-11-07","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2013","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-13-000045","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-13-000045/files/vrtx-20130930.xml","financials":{"income_statement":{"net_income_loss_available_to_common_stockholders_basic":{"value":-124132000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_before_equity_method_investments":{"value":-129413000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"research_and_development":{"value":228624000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":19339000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"costs_and_expenses":{"value":355765000.0,"unit":"USD","label":"Costs And Expenses","order":600},"revenues":{"value":221700000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":-134065000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_average_shares":{"value":230505000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":-124132000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_earnings_per_share":{"value":-0.54,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-4530000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":335717000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_before_tax":{"value":-129413000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_average_shares":{"value":230505000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":-128662000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"selling_general_and_administrative_expenses":{"value":87754000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":201652000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue_goods":{"value":20048000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss":{"value":-128662000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue":{"value":20048000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_tax_expense_benefit":{"value":-751000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":-0.54,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"benefits_costs_expenses":{"value":351113000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200}},"cash_flow_statement":{"net_cash_flow":{"value":55046000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":13006000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":49536000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":49536000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":3112000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities_continuing":{"value":-13720000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":-13720000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":13006000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":51934000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"noncurrent_liabilities":{"value":686569000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"fixed_assets":{"value":648924000.0,"unit":"USD","label":"Fixed Assets","order":320},"assets":{"value":2582748000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":285193000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"inventory":{"value":13537000.0,"unit":"USD","label":"Inventory","order":230},"liabilities_and_equity":{"value":2582748000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":182168000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":1096068000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":357966000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":1264888000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":1447056000.0,"unit":"USD","label":"Equity","order":1400},"other_current_assets":{"value":1635094000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":51533000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":409499000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":1648631000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":934117000.0,"unit":"USD","label":"Noncurrent Assets","order":300}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":680000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-123452000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-127982000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-4530000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}}}},{"start_date":"2013-01-01","end_date":"2013-12-31","filing_date":"2014-02-11","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2013","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-14-000015","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-14-000015/files/vrtx-20131231.xml","financials":{"income_statement":{"income_tax_expense_benefit_current":{"value":-8200000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"diluted_earnings_per_share":{"value":-1.98,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":362342000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":-288567000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-242522000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":224906000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"benefits_costs_expenses":{"value":2188092000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit_deferred":{"value":-280367000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"other_operating_expenses":{"value":745319000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_expenses":{"value":2026444000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":-687550000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":1211975000.0,"unit":"USD","label":"Revenues","order":100},"cost_of_revenue":{"value":88979000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":-976117000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss":{"value":-687550000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_before_tax":{"value":-976117000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"costs_and_expenses":{"value":2115423000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":-445028000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":224906000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":-1.98,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"research_and_development":{"value":918783000.0,"unit":"USD","label":"Research and Development","order":1030},"gross_profit":{"value":1122996000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue_goods":{"value":88979000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_income_loss":{"value":-903448000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_available_to_common_stockholders_basic":{"value":-445028000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}},"balance_sheet":{"equity_attributable_to_parent":{"value":1356405000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":33554000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":2319041000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":962636000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":1574429000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":1356405000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":1588576000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":271717000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":730465000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":14147000.0,"unit":"USD","label":"Inventory","order":230},"accounts_payable":{"value":49327000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":564807000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"wages":{"value":76785000.0,"unit":"USD","label":"Wages","order":730},"fixed_assets":{"value":696911000.0,"unit":"USD","label":"Fixed Assets","order":320},"assets":{"value":2319041000.0,"unit":"USD","label":"Assets","order":100},"current_liabilities":{"value":397829000.0,"unit":"USD","label":"Current Liabilities","order":700}},"comprehensive_income":{"comprehensive_income_loss":{"value":-687306000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":244000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-242522000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-444784000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":180884000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":79892000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-54130000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":84600000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":-51570000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-54130000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":4708000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities_continuing":{"value":-51570000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":180884000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}}}},{"start_date":"2014-01-01","end_date":"2014-03-31","filing_date":"2014-05-05","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2014","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-14-000026","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-14-000026/files/vrtx-20140331.xml","financials":{"balance_sheet":{"current_assets":{"value":1430330000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":726204000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":323929000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":766778000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":2197108000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":11261000.0,"unit":"USD","label":"Inventory","order":230},"other_current_assets":{"value":1419069000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":40574000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":2197108000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":373500000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":966230000.0,"unit":"USD","label":"Liabilities","order":600},"accounts_payable":{"value":49571000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":592730000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":1230878000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":1230878000.0,"unit":"USD","label":"Equity","order":1400}},"income_statement":{"cost_of_revenue":{"value":8572000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"interest_income_expense_operating_net":{"value":-15717000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"gross_profit":{"value":109879000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"costs_and_expenses":{"value":334493000.0,"unit":"USD","label":"Costs And Expenses","order":600},"research_and_development":{"value":238617000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_before_equity_method_investments":{"value":-231308000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"cost_of_revenue_goods":{"value":8572000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":325921000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_earnings_per_share":{"value":-1,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_earnings_per_share":{"value":-1,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"interest_income_expense_after_provision_for_losses":{"value":-15717000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"selling_general_and_administrative_expenses":{"value":74212000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_discontinued_operations_net_of_tax":{"value":-346000,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"basic_average_shares":{"value":232887000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit":{"value":803000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_income_loss":{"value":-216042000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":118451000.0,"unit":"USD","label":"Revenues","order":100},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"net_income_loss_available_to_common_stockholders_basic":{"value":-232457000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_after_tax":{"value":-232111000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_from_continuing_operations_before_tax":{"value":-231308000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_parent":{"value":-232457000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss":{"value":-232457000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":232887000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":349759000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"other_operating_expenses":{"value":13092000.0,"unit":"USD","label":"Other Operating Expenses","order":1040}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":50416000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-20407000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-20407000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":50416000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":-175762000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":-144755000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"exchange_gains_losses":{"value":499000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":-175762000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":-145254000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"comprehensive_income":{"comprehensive_income_loss":{"value":-232448000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":9000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-232448000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2014-04-01","end_date":"2014-06-30","filing_date":"2014-07-31","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2014","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-14-000058","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-14-000058/files/vrtx-20140630.xml","financials":{"income_statement":{"selling_general_and_administrative_expenses":{"value":77446000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"other_operating_expenses":{"value":7375000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_expenses":{"value":309308000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":-180542000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"interest_income_expense_after_provision_for_losses":{"value":-15585000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_discontinued_operations_net_of_tax":{"value":-293000,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_before_tax":{"value":-158396000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"research_and_development":{"value":224487000.0,"unit":"USD","label":"Research and Development","order":1030},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"gross_profit":{"value":128766000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_average_shares":{"value":233808000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"diluted_earnings_per_share":{"value":-0.68,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"costs_and_expenses":{"value":318963000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_earnings_per_share":{"value":-0.68,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_available_to_common_stockholders_basic":{"value":-159382000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss":{"value":-159382000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue":{"value":9655000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"cost_of_revenue_goods":{"value":9655000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":-159089000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":138421000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":296817000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"net_income_loss_attributable_to_parent":{"value":-159382000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":233808000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_before_equity_method_investments":{"value":-158396000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"interest_income_expense_operating_net":{"value":-15585000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"income_tax_expense_benefit":{"value":693000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"cash_flow_statement":{"net_cash_flow":{"value":-2341000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-3487000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":-127920000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":33405000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":1146000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":33405000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":89882000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":89882000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":-127920000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":274000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-159108000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-159108000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"assets":{"value":2117820000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":307610000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_liabilities":{"value":582578000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":770436000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"fixed_assets":{"value":730000000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity":{"value":1172269000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":362973000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":2117820000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":11982000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":945551000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":1347384000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":1172269000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":55363000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":1335402000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":40436000.0,"unit":"USD","label":"Other Non-current Assets","order":350}}}},{"start_date":"2014-07-01","end_date":"2014-09-30","filing_date":"2014-11-06","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2014","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-14-000063","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-14-000063/files/vrtx-20140930.xml","financials":{"balance_sheet":{"equity_attributable_to_parent":{"value":1155905000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_assets":{"value":755990000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity":{"value":1155905000.0,"unit":"USD","label":"Equity","order":1400},"liabilities_and_equity":{"value":2406086000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":16753000.0,"unit":"USD","label":"Inventory","order":230},"other_noncurrent_assets":{"value":35112000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":1250181000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":333706000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_liabilities":{"value":878003000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":1650096000.0,"unit":"USD","label":"Current Assets","order":200},"accounts_payable":{"value":38472000.0,"unit":"USD","label":"Accounts Payable","order":710},"assets":{"value":2406086000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":720878000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":372178000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":1633343000.0,"unit":"USD","label":"Other Current Assets","order":250}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-168876000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":1184000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-168876000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":30545000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":357233000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":-87647000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":-87647000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":295879000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"exchange_gains_losses":{"value":-2126000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":30545000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":357233000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":298005000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"operating_income_loss":{"value":-142203000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":3419000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"interest_income_expense_operating_net":{"value":-20384000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"costs_and_expenses":{"value":321190000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_average_shares":{"value":236137000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_discontinued_operations_net_of_tax":{"value":-64000,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"income_loss_before_equity_method_investments":{"value":-166577000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_earnings_per_share":{"value":-0.72,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":-170060000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_attributable_to_parent":{"value":-170060000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":236137000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue":{"value":10208000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_expenses":{"value":310982000.0,"unit":"USD","label":"Operating Expenses","order":1000},"revenues":{"value":178987000.0,"unit":"USD","label":"Revenues","order":100},"diluted_earnings_per_share":{"value":-0.72,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"gross_profit":{"value":168779000.0,"unit":"USD","label":"Gross Profit","order":800},"research_and_development":{"value":190939000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_income_expense_after_provision_for_losses":{"value":-20384000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"selling_general_and_administrative_expenses":{"value":75224000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss":{"value":-170060000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue_goods":{"value":10208000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_before_tax":{"value":-166577000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":44819000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"benefits_costs_expenses":{"value":345564000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_after_tax":{"value":-169996000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400}}}},{"start_date":"2014-01-01","end_date":"2014-12-31","filing_date":"2015-02-13","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2014","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-15-000012","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-15-000012/files/vrtx-20141231.xml","financials":{"balance_sheet":{"liabilities":{"value":1238496000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":72356000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"prepaid_expenses":{"value":17569000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"equity_attributable_to_noncontrolling_interest":{"value":21177000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":205885000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":30848000.0,"unit":"USD","label":"Inventory","order":230},"current_assets":{"value":1546511000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":368254000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":788168000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":1498094000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":870242000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity":{"value":1096183000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_parent":{"value":1075006000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":2334679000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":2334679000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"wages":{"value":91175000.0,"unit":"USD","label":"Wages","order":730},"accounts_payable":{"value":71194000.0,"unit":"USD","label":"Accounts Payable","order":710},"fixed_assets":{"value":715812000.0,"unit":"USD","label":"Fixed Assets","order":320}},"income_statement":{"basic_earnings_per_share":{"value":-3.14,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-4190000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":235307000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"selling_general_and_administrative_expenses":{"value":305409000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":540690000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_available_to_common_stockholders_basic":{"value":-737643000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_before_tax":{"value":-734875000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":72187000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":-912000,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"revenues":{"value":580415000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_discontinued_operations_net_of_tax":{"value":-912000,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"benefits_costs_expenses":{"value":1315290000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"cost_of_revenue":{"value":39725000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":-738555000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":1233102000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":-734875000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"cost_of_revenue_goods":{"value":39725000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_tax_expense_benefit_current":{"value":6676000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"income_tax_expense_benefit":{"value":6958000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_after_tax":{"value":-741833000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_average_shares":{"value":235307000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":-3.14,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"research_and_development":{"value":855506000.0,"unit":"USD","label":"Research and Development","order":1030},"preferred_stock_dividends_and_other_adjustments":{"value":-912000,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"costs_and_expenses":{"value":1272827000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_income_loss":{"value":-692412000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss":{"value":-742745000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit_deferred":{"value":282000,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":73959000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":-513199000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":53784000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":497376000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":73959000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":-513199000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":55960000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":-2176000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":497376000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss":{"value":-741522000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-737332000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":1223000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-4190000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}}}},{"start_date":"2015-01-01","end_date":"2015-03-31","filing_date":"2015-05-04","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2015","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-15-000029","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-15-000029/files/vrtx-20150331.xml","financials":{"income_statement":{"net_income_loss_attributable_to_noncontrolling_interest":{"value":-98000,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":-198606000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_discontinued_operations_net_of_tax":{"value":0,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"research_and_development":{"value":215599000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_from_continuing_operations_after_tax":{"value":-198704000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_attributable_to_parent":{"value":-198606000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":129128000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue":{"value":9381000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_from_continuing_operations_before_tax":{"value":-198405000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"cost_of_revenue_goods":{"value":9381000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":301113000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":-171985000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_earnings_per_share":{"value":-0.83,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":-198704000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":239493000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":336914000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"selling_general_and_administrative_expenses":{"value":85860000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_operating_net":{"value":-21307000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"revenues":{"value":138509000.0,"unit":"USD","label":"Revenues","order":100},"basic_earnings_per_share":{"value":-0.83,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_before_equity_method_investments":{"value":-198405000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_average_shares":{"value":239493000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"other_operating_expenses":{"value":-346000,"unit":"USD","label":"Other Operating Expenses","order":1040},"interest_income_expense_after_provision_for_losses":{"value":-21307000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"costs_and_expenses":{"value":310494000.0,"unit":"USD","label":"Costs And Expenses","order":600},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":299000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":-207181000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":214038000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":-207181000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":37024000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":35359000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":214038000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":35359000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":39620000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":-2596000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000}},"comprehensive_income":{"comprehensive_income_loss":{"value":-198830000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":-126000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-98000,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-198732000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"current_assets":{"value":1358203000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":997537000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":1168290000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":34089000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":976458000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":21079000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":2165827000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":99008000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_liabilities":{"value":302438000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":2165827000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":865852000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":807624000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":1324114000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":708616000.0,"unit":"USD","label":"Fixed Assets","order":320},"accounts_payable":{"value":43524000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":258914000.0,"unit":"USD","label":"Other Current Liabilities","order":740}}}},{"start_date":"2015-04-01","end_date":"2015-06-30","filing_date":"2015-08-04","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2015","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-15-000047","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-15-000047/files/vrtx-20150630.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":-2498000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-223490000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-32144000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-191346000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"liabilities_and_equity":{"value":2374073000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":153252000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":1294689000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":1048216000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":1325857000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":2374073000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":713378000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":366006000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_liabilities":{"value":373823000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":42113000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":952034000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_liabilities":{"value":301120000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":894964000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":1252576000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":72703000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_assets":{"value":1079384000.0,"unit":"USD","label":"Noncurrent Assets","order":300}},"income_statement":{"gross_profit":{"value":150667000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_available_to_common_stockholders_basic":{"value":-188848000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":223858000.0,"unit":"USD","label":"Research and Development","order":1030},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_earnings_per_share":{"value":-0.78,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_after_tax":{"value":-220992000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":30131000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_parent":{"value":-188848000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue_goods":{"value":15409000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_earnings_per_share":{"value":-0.78,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":356937000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":-220992000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":337240000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-32144000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"interest_income_expense_operating_net":{"value":-21111000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"interest_income_expense_after_provision_for_losses":{"value":-21111000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"basic_average_shares":{"value":240757000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue":{"value":15409000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"other_operating_expenses":{"value":3579000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_expenses":{"value":321831000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":-171164000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_average_shares":{"value":240757000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_before_equity_method_investments":{"value":-190861000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_loss_from_discontinued_operations_net_of_tax":{"value":0,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"income_loss_from_continuing_operations_before_tax":{"value":-190861000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":94394000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":166076000.0,"unit":"USD","label":"Revenues","order":100}},"cash_flow_statement":{"net_cash_flow":{"value":206954000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":21144000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":1290000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":-95213000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":278443000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":21144000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":-95213000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":205664000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":278443000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}}}},{"start_date":"2015-07-01","end_date":"2015-09-30","filing_date":"2015-10-30","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2015","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-15-000056","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-15-000056/files/vrtx-20150930.xml","financials":{"cash_flow_statement":{"exchange_gains_losses":{"value":-953000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities_continuing":{"value":-47024000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":-112034000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-100935000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":34619000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-100935000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":-112987000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":34619000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":-47024000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"balance_sheet":{"liabilities_and_equity":{"value":2433993000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":1076732000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":982302000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":1074541000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":78899000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_assets":{"value":1310255000.0,"unit":"USD","label":"Other Current Assets","order":250},"inventory":{"value":49197000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":706670000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":154585000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":367871000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":1357261000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_parent":{"value":922147000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":2433993000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":296060000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":374959000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":1359452000.0,"unit":"USD","label":"Current Assets","order":200}},"comprehensive_income":{"comprehensive_income_loss":{"value":-90598000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":1333000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":3218000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-91931000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"net_income_loss_available_to_common_stockholders_basic":{"value":-95149000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":246284000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":-0.39,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":-93816000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":3517000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_after_tax":{"value":-93816000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_average_shares":{"value":241969000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"costs_and_expenses":{"value":379842000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_discontinued_operations_net_of_tax":{"value":0,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"income_tax_expense_benefit":{"value":1330000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"benefits_costs_expenses":{"value":402302000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"gross_profit":{"value":279547000.0,"unit":"USD","label":"Gross Profit","order":800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"operating_income_loss":{"value":-70026000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue_goods":{"value":30269000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_before_equity_method_investments":{"value":-92486000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_average_shares":{"value":241969000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"selling_general_and_administrative_expenses":{"value":99772000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":-92486000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":-0.39,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"interest_income_expense_after_provision_for_losses":{"value":-21134000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"operating_expenses":{"value":349573000.0,"unit":"USD","label":"Operating Expenses","order":1000},"cost_of_revenue":{"value":30269000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"revenues":{"value":309816000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":-95149000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"interest_income_expense_operating_net":{"value":-21134000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":1333000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}}}},{"start_date":"2015-01-01","end_date":"2015-12-31","filing_date":"2016-02-16","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2015","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-16-000067","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-16-000067/files/vrtx-20151231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":268856000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":-2834000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":89509000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":-365432000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":188919000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":86675000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":188919000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":268856000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":-365432000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-555427000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":907000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-31847000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-587274000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"income_loss_before_equity_method_investments":{"value":-557800000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_earnings_per_share":{"value":-2.31,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_tax_expense_benefit_current":{"value":30083000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"diluted_average_shares":{"value":241312000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_discontinued_operations_net_of_tax":{"value":0,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"cost_of_revenue_goods":{"value":117151000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"costs_and_expenses":{"value":1499215000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":-556334000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"selling_general_and_administrative_expenses":{"value":376575000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_average_shares":{"value":241312000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"other_operating_expenses":{"value":9567000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"gross_profit":{"value":915185000.0,"unit":"USD","label":"Gross Profit","order":800},"income_tax_expense_benefit":{"value":30381000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"research_and_development":{"value":995922000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":117151000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_available_to_common_stockholders_basic":{"value":-556334000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-31847000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":1590136000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":-588181000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_before_tax":{"value":-557800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"diluted_earnings_per_share":{"value":-2.31,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_income_loss":{"value":-466879000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":1382064000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_tax_expense_benefit_deferred":{"value":298000,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_loss_from_continuing_operations_after_tax":{"value":-588181000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":1032336000.0,"unit":"USD","label":"Revenues","order":100}},"balance_sheet":{"liabilities":{"value":1405247000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_parent":{"value":939967000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":1091722000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":57207000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":343534000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":2498875000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":898898000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_noncurrent_assets":{"value":394007000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"accounts_payable":{"value":74942000.0,"unit":"USD","label":"Accounts Payable","order":710},"wages":{"value":87873000.0,"unit":"USD","label":"Wages","order":730},"current_assets":{"value":1407153000.0,"unit":"USD","label":"Current Assets","order":200},"redeemable_noncontrolling_interest_preferred":{"value":0,"unit":"USD","label":"Redeemable Noncontrolling Interest, Preferred","order":1300},"current_liabilities":{"value":506349000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":2498875000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":697715000.0,"unit":"USD","label":"Fixed Assets","order":320},"redeemable_noncontrolling_interest":{"value":0,"unit":"USD","label":"Redeemable Noncontrolling Interest","order":1000},"equity":{"value":1093628000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":153661000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"temporary_equity":{"value":0,"unit":"USD","label":"Temporary Equity","order":1700},"other_current_assets":{"value":1327888000.0,"unit":"USD","label":"Other Current Assets","order":250},"prepaid_expenses":{"value":22058000.0,"unit":"USD","label":"Prepaid Expenses","order":240}}}},{"start_date":"2016-01-01","end_date":"2016-03-31","filing_date":"2016-05-03","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2016","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-16-000078","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-16-000078/files/vrtx-20160331.xml","financials":{"balance_sheet":{"other_current_assets":{"value":1339635000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":1116198000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":1085071000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":63200000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":476820000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":957079000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":2487906000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1371708000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":394550000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":159119000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"accounts_payable":{"value":75221000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":552041000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":819667000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":1402835000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":690521000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":2487906000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-48354000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-6723000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-42825000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":5529000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"interest_income_expense_operating_net":{"value":-20698000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"selling_general_and_administrative_expenses":{"value":105214000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":5529000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"gross_profit":{"value":348291000.0,"unit":"USD","label":"Gross Profit","order":800},"revenues":{"value":398080000.0,"unit":"USD","label":"Revenues","order":100},"basic_earnings_per_share":{"value":-0.17,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":-41631000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_after_tax":{"value":-36102000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"interest_income_expense_after_provision_for_losses":{"value":-20698000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_expenses":{"value":362621000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":-14330000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_parent":{"value":-41631000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"benefits_costs_expenses":{"value":428697000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":243831000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":-0.17,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"cost_of_revenue_goods":{"value":49789000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"costs_and_expenses":{"value":412410000.0,"unit":"USD","label":"Costs And Expenses","order":600},"research_and_development":{"value":255860000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":49789000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_loss_from_continuing_operations_before_tax":{"value":-30617000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_before_equity_method_investments":{"value":-30617000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss":{"value":-36102000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":5485000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"other_operating_expenses":{"value":1547000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_average_shares":{"value":243831000.0,"unit":"shares","label":"Diluted Average Shares","order":4500}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":4702000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":-113143000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":4702000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":-15137000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-102708000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":2620000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow":{"value":-110523000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":-15137000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-102708000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}}}},{"start_date":"2016-04-01","end_date":"2016-06-30","filing_date":"2016-08-01","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2016","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-16-000091","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-16-000091/files/vrtx-20160630.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":40860000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":1621000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":21253000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-57782000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":40860000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-57782000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":-2710000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":4331000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":21253000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":28374000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":1509000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-34642000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-63016000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"current_liabilities":{"value":622855000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":404225000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":1387561000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":51302000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_noncontrolling_interest":{"value":187491000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":1454150000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":1168845000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":1380137000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":2548982000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":2548982000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":690607000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_parent":{"value":981354000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_liabilities":{"value":571553000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":66589000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":757282000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":1094832000.0,"unit":"USD","label":"Noncurrent Assets","order":300}},"income_statement":{"revenues":{"value":431608000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit":{"value":18130000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_before_equity_method_investments":{"value":-18021000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_before_tax":{"value":-18021000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_from_continuing_operations_after_tax":{"value":-36151000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"gross_profit":{"value":387454000.0,"unit":"USD","label":"Gross Profit","order":800},"interest_income_expense_operating_net":{"value":-20155000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"benefits_costs_expenses":{"value":449629000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_parent":{"value":-64525000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"basic_average_shares":{"value":244482000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"research_and_development":{"value":271008000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_expenses":{"value":384101000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":244482000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"interest_income_expense_after_provision_for_losses":{"value":-20155000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"diluted_earnings_per_share":{"value":-0.26,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"other_operating_expenses":{"value":1441000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"cost_of_revenue":{"value":44154000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_income_loss":{"value":3353000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue_goods":{"value":44154000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_available_to_common_stockholders_basic":{"value":-64525000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"selling_general_and_administrative_expenses":{"value":111652000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":28374000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_earnings_per_share":{"value":-0.26,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":-36151000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":428255000.0,"unit":"USD","label":"Costs And Expenses","order":600}}}},{"start_date":"2016-07-01","end_date":"2016-09-30","filing_date":"2016-10-31","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2016","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-16-000107","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-16-000107/files/vrtx-20160930.xml","financials":{"income_statement":{"basic_earnings_per_share":{"value":-0.16,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"basic_average_shares":{"value":244920000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_average_shares":{"value":244920000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue_goods":{"value":53222000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":379288000.0,"unit":"USD","label":"Operating Expenses","order":1000},"other_operating_expenses":{"value":863000,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-696000,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_before_equity_method_investments":{"value":-39034000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"costs_and_expenses":{"value":432510000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_before_tax":{"value":-39034000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"benefits_costs_expenses":{"value":452817000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"operating_income_loss":{"value":-18727000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_earnings_per_share":{"value":-0.16,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"interest_income_expense_after_provision_for_losses":{"value":-20140000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"interest_income_expense_operating_net":{"value":-20140000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"net_income_loss":{"value":-39537000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":272370000.0,"unit":"USD","label":"Research and Development","order":1030},"selling_general_and_administrative_expenses":{"value":106055000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":360561000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue":{"value":53222000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"revenues":{"value":413783000.0,"unit":"USD","label":"Revenues","order":100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":-38841000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_after_tax":{"value":-39537000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_attributable_to_parent":{"value":-38841000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_tax_expense_benefit":{"value":503000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":65656000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":13554000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":114001000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":113826000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":13554000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":34791000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":65656000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-175000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities_continuing":{"value":34791000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"balance_sheet":{"assets":{"value":2609641000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_assets":{"value":1107740000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":2609641000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"accounts_payable":{"value":50914000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":1501901000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities":{"value":1401300000.0,"unit":"USD","label":"Liabilities","order":600},"fixed_assets":{"value":687613000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":722841000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":186795000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":71799000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":671927000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity":{"value":1208341000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":420127000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":678459000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":1021546000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":1430102000.0,"unit":"USD","label":"Other Current Assets","order":250}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-696000,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-39992000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-39296000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-455000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2016-01-01","end_date":"2016-12-31","filing_date":"2017-02-23","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2016","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-17-000017","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-17-000017/files/vrtx-20161231.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":19349000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-92703000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-64682000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":28021000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"basic_earnings_per_share":{"value":-0.46,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"costs_and_expenses":{"value":1692241000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_before_tax":{"value":-67366000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":4911000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_discontinued_operations_net_of_tax":{"value":0,"unit":"USD","label":"Income/Loss From Discontinued Operations Net Of Tax","order":1600},"basic_average_shares":{"value":244685000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_parent":{"value":-112052000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":1495366000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":28021000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":1047690000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue_goods":{"value":206811000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":-84031000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":-112052000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit_current":{"value":-191000,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"cost_of_revenue":{"value":206811000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":-67366000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_tax_expense_benefit_deferred":{"value":16856000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"selling_general_and_administrative_expenses":{"value":432829000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit":{"value":16665000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_average_shares":{"value":244685000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_expenses":{"value":1485430000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_earnings_per_share":{"value":-0.46,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":1769543000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"operating_income_loss":{"value":9936000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":1702177000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss":{"value":-84031000.0,"unit":"USD","label":"Net Income/Loss","order":3200}},"balance_sheet":{"other_current_liabilities":{"value":644699000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"wages":{"value":86387000.0,"unit":"USD","label":"Wages","order":730},"inventory":{"value":77604000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":2896787000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1558596000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":1717802000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":698362000.0,"unit":"USD","label":"Fixed Assets","order":320},"prepaid_expenses":{"value":36134000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"other_noncurrent_assets":{"value":366885000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":1156582000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":792537000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":766059000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities_and_equity":{"value":2896787000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":1338191000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":181609000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":1831540000.0,"unit":"USD","label":"Current Assets","order":200},"accounts_payable":{"value":61451000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_assets":{"value":1065247000.0,"unit":"USD","label":"Noncurrent Assets","order":300}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":104469000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":469177000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":104469000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":133271000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":236103000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"exchange_gains_losses":{"value":-4666000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":133271000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":236103000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":464511000.0,"unit":"USD","label":"Net Cash Flow","order":1100}}}},{"start_date":"2017-01-01","end_date":"2017-03-31","filing_date":"2017-04-28","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2017","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-17-000030","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-17-000030/files/vrtx-20170331.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":242608000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-5148000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":244400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":1792000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"operating_expenses":{"value":397634000.0,"unit":"USD","label":"Operating Expenses","order":1000},"research_and_development":{"value":273563000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":46242000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"basic_average_shares":{"value":246024000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":249548000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_earnings_per_share":{"value":1.01,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"revenues":{"value":714718000.0,"unit":"USD","label":"Revenues","order":100},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":406000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"income_loss_before_equity_method_investments":{"value":253533000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss":{"value":249548000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":248700000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":247756000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"costs_and_expenses":{"value":443876000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":3985000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_before_tax":{"value":253533000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_income_loss":{"value":270842000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"other_operating_expenses":{"value":10745000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":247350000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"benefits_costs_expenses":{"value":461185000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_income_expense_after_provision_for_losses":{"value":-16765000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"diluted_earnings_per_share":{"value":0.99,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":113326000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":1792000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"interest_income_expense_operating_net":{"value":-16765000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"cost_of_revenue_goods":{"value":46242000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"gross_profit":{"value":668476000.0,"unit":"USD","label":"Gross Profit","order":800}},"cash_flow_statement":{"net_cash_flow":{"value":-180266000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-181654000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-289565000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-157781000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":265692000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":265692000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":1388000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-289565000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-157781000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"balance_sheet":{"other_noncurrent_assets":{"value":366494000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":1789794000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":182785000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":1500008000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":1871814000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":1074889000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":2946703000.0,"unit":"USD","label":"Assets","order":100},"accounts_payable":{"value":63145000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities":{"value":1263910000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":1682793000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":489796000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":774114000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":82020000.0,"unit":"USD","label":"Inventory","order":230},"liabilities_and_equity":{"value":2946703000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":708395000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":426651000.0,"unit":"USD","label":"Other Current Liabilities","order":740}}}},{"start_date":"2017-04-01","end_date":"2017-06-30","filing_date":"2017-07-28","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2017","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-17-000047","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-17-000047/files/vrtx-20170630.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-19782000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":13173000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-37778000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":-6609000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"balance_sheet":{"equity_attributable_to_parent":{"value":1671273000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":1105022000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":3285594000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":1867231000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":549465000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_noncontrolling_interest":{"value":195958000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":1418363000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":2088309000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":792957000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":92263000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":740103000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":625406000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":364919000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":3285594000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"accounts_payable":{"value":75941000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":2180572000.0,"unit":"USD","label":"Current Assets","order":200}},"income_statement":{"interest_income_expense_operating_net":{"value":-14664000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"net_income_loss_available_to_common_stockholders_basic":{"value":17973000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"benefits_costs_expenses":{"value":508629000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_earnings_per_share":{"value":0.07,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"cost_of_revenue":{"value":70535000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"cost_of_revenue_goods":{"value":70535000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"revenues":{"value":544135000.0,"unit":"USD","label":"Revenues","order":100},"other_operating_expenses":{"value":4193000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":13173000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":251635000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_after_tax":{"value":31169000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_income_loss":{"value":52707000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_before_tax":{"value":35506000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"gross_profit":{"value":473600000.0,"unit":"USD","label":"Gross Profit","order":800},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":23000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"basic_earnings_per_share":{"value":0.07,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_tax_expense_benefit":{"value":4337000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":31169000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_parent":{"value":17996000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":247521000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_expenses":{"value":420893000.0,"unit":"USD","label":"Operating Expenses","order":1000},"interest_income_expense_after_provision_for_losses":{"value":-14664000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"selling_general_and_administrative_expenses":{"value":127249000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"research_and_development":{"value":289451000.0,"unit":"USD","label":"Research and Development","order":1030},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_before_equity_method_investments":{"value":35506000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"costs_and_expenses":{"value":491428000.0,"unit":"USD","label":"Costs And Expenses","order":600},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":181653000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":132033000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":217339000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":132033000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":2112000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities_continuing":{"value":-96347000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":181653000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":219451000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-96347000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}}}},{"start_date":"2017-07-01","end_date":"2017-09-30","filing_date":"2017-10-30","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2017","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-17-000060","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-17-000060/files/vrtx-20170930.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":152705000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-162456000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":170086000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":170086000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-162456000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":160335000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":1501000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":152705000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":161836000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"balance_sheet":{"inventory":{"value":98192000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":1395081000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":870351000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":1791077000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"fixed_assets":{"value":759978000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_liabilities":{"value":684342000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":710739000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_liabilities":{"value":633601000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":3198325000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":12167000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":110373000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":2327974000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":2229782000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":77138000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities_and_equity":{"value":3198325000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":1803244000.0,"unit":"USD","label":"Equity","order":1400}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-188315000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-294643000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":-106328000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-3376000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"income_statement":{"diluted_earnings_per_share":{"value":-0.41,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_from_continuing_operations_after_tax":{"value":-291267000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_income_loss":{"value":-326043000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_before_tax":{"value":-417170000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":120710000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_after_provision_for_losses":{"value":-13574000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-188315000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"cost_of_revenue":{"value":72186000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":-102952000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"revenues":{"value":578165000.0,"unit":"USD","label":"Revenues","order":100},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_loss_before_equity_method_investments":{"value":-417170000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_earnings_per_share":{"value":-0.41,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue_goods":{"value":72186000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"research_and_development":{"value":454947000.0,"unit":"USD","label":"Research and Development","order":1030},"benefits_costs_expenses":{"value":995335000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_income_expense_operating_net":{"value":-13574000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"costs_and_expenses":{"value":904208000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":-125903000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_expenses":{"value":832022000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":250268000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"other_operating_expenses":{"value":256365000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":-102952000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_average_shares":{"value":250268000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"gross_profit":{"value":505979000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss":{"value":-291267000.0,"unit":"USD","label":"Net Income/Loss","order":3200}}}},{"start_date":"2017-01-01","end_date":"2017-12-31","filing_date":"2018-02-15","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2017","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-18-000009","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-18-000009/files/vrtx-20171231.xml","financials":{"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":13727000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":111830000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":696448000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":2648963000.0,"unit":"USD","label":"Current Assets","order":200},"wages":{"value":113026000.0,"unit":"USD","label":"Wages","order":730},"assets":{"value":3546014000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":789437000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":107614000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"prepaid_expenses":{"value":62475000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"liabilities_and_equity":{"value":3546014000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":2042306000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":807260000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":2028579000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":897051000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_liabilities":{"value":620240000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"accounts_payable":{"value":73994000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities":{"value":1503708000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":2474658000.0,"unit":"USD","label":"Other Current Assets","order":250}},"income_statement":{"basic_average_shares":{"value":248858000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":1.04,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":91635000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":-107324000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_parent":{"value":263484000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"costs_and_expenses":{"value":2365409000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit_deferred":{"value":-127484000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_loss_before_equity_method_investments":{"value":-15689000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":123243000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":2092734000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":91635000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":293000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"benefits_costs_expenses":{"value":2504341000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"research_and_development":{"value":1324625000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_earnings_per_share":{"value":1.06,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-171849000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"other_operating_expenses":{"value":272030000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"selling_general_and_administrative_expenses":{"value":496079000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":2215977000.0,"unit":"USD","label":"Gross Profit","order":800},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":586000,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_average_shares":{"value":253225000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"cost_of_revenue":{"value":272675000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"preferred_stock_dividends_and_other_adjustments":{"value":293000,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":263191000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue_goods":{"value":272675000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"revenues":{"value":2488652000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_before_tax":{"value":-15689000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit_current":{"value":20160000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":-32745000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-171849000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":230739000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":58890000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-437681000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-437681000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":68404000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":5802000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities_continuing":{"value":844942000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":844942000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":481467000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":475665000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":68404000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}}}},{"start_date":"2018-01-01","end_date":"2018-03-31","filing_date":"2018-04-27","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2018","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-18-000014","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-18-000014/files/vrtx-20180331.xml","financials":{"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":640799000.0,"unit":"USD","label":"Revenues","order":100},"interest_income_expense_after_provision_for_losses":{"value":-11097000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"costs_and_expenses":{"value":511898000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_after_tax":{"value":227301000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss":{"value":227301000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"benefits_costs_expenses":{"value":426157000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"cost_of_revenue":{"value":71613000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_expenses":{"value":440285000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_before_tax":{"value":214642000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"gross_profit":{"value":569186000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue_goods":{"value":71613000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_available_to_common_stockholders_basic":{"value":210164000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":17038000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_attributable_to_parent":{"value":210263000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"research_and_development":{"value":310553000.0,"unit":"USD","label":"Research and Development","order":1030},"selling_general_and_administrative_expenses":{"value":129808000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_operating_net":{"value":-11097000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"basic_average_shares":{"value":253231000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":99000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"diluted_earnings_per_share":{"value":0.81,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit":{"value":-12659000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_before_equity_method_investments":{"value":214642000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":128901000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_average_shares":{"value":258526000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":0.83,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}},"cash_flow_statement":{"exchange_gains_losses":{"value":1656000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":336546000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":252657000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":252657000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":78956000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":338202000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":4933000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":4933000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":78956000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":17038000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-4051000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":206212000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":223250000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"balance_sheet":{"equity":{"value":2430821000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":29765000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":800670000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_liabilities":{"value":694841000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":74062000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_assets":{"value":911858000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":3041116000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":3952974000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1522153000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":3952974000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_liabilities":{"value":753250000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":827312000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":2401056000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":2923770000.0,"unit":"USD","label":"Other Current Assets","order":250},"inventory":{"value":117346000.0,"unit":"USD","label":"Inventory","order":230},"other_noncurrent_assets":{"value":111188000.0,"unit":"USD","label":"Other Non-current Assets","order":350}}}},{"start_date":"2018-04-01","end_date":"2018-06-30","filing_date":"2018-07-26","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2018","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-18-000022","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-18-000022/files/vrtx-20180630.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":321703000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-5857000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":154197000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-116298000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":321703000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-51208000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-51208000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-116298000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":148340000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"balance_sheet":{"accounts_payable":{"value":83034000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":693203000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":1620503000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":844266000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":927300000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":115025000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":2686228000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":3292398000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":927963000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":4335386000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":4335386000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":28655000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":112035000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"fixed_assets":{"value":815928000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_assets":{"value":3407423000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":2714883000.0,"unit":"USD","label":"Equity","order":1400}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":35138000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":241388000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-1110000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":242498000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":62000,"unit":"USD","label":"Other Operating Expenses","order":1040},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":65000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"net_income_loss_available_to_common_stockholders_basic":{"value":207295000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"selling_general_and_administrative_expenses":{"value":137303000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_after_provision_for_losses":{"value":-10106000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"cost_of_revenue":{"value":104382000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":216591000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_average_shares":{"value":258584000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"cost_of_revenue_goods":{"value":104382000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-1110000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":474897000.0,"unit":"USD","label":"Operating Expenses","order":1000},"benefits_costs_expenses":{"value":535566000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":216591000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":0.82,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"operating_income_loss":{"value":172878000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_after_tax":{"value":206250000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_earnings_per_share":{"value":0.8,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":206250000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"revenues":{"value":752157000.0,"unit":"USD","label":"Revenues","order":100},"research_and_development":{"value":337532000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_income_expense_operating_net":{"value":-10106000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":254135000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"costs_and_expenses":{"value":579279000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":207360000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":647775000.0,"unit":"USD","label":"Gross Profit","order":800},"income_tax_expense_benefit":{"value":10341000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}}}},{"start_date":"2018-07-01","end_date":"2018-09-30","filing_date":"2018-10-25","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2018","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-18-000029","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-18-000029/files/vrtx-20180930.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":381348000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-555000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":333538000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":2079000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-49889000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-49889000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":332983000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":2079000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":381348000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"income_statement":{"net_income_loss":{"value":128456000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":330510000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_income_loss":{"value":205649000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":0.51,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue":{"value":111255000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":259788000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"interest_income_expense_operating_net":{"value":-8143000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"basic_average_shares":{"value":254905000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":14000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"interest_income_expense_after_provision_for_losses":{"value":-8143000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_expenses":{"value":467631000.0,"unit":"USD","label":"Operating Expenses","order":1000},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_loss_from_continuing_operations_before_tax":{"value":136511000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":137295000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-290000,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":128732000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit":{"value":8055000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":0.5,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"costs_and_expenses":{"value":578886000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_after_tax":{"value":128456000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"gross_profit":{"value":673280000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_parent":{"value":128746000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"benefits_costs_expenses":{"value":648024000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_before_equity_method_investments":{"value":136511000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"revenues":{"value":784535000.0,"unit":"USD","label":"Revenues","order":100}},"balance_sheet":{"other_noncurrent_assets":{"value":125877000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":4620840000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":693851000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":2906116000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":92149000.0,"unit":"USD","label":"Accounts Payable","order":710},"fixed_assets":{"value":808352000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":124150000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":900359000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":934229000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":992508000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":28365000.0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":1686359000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":2934481000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":4620840000.0,"unit":"USD","label":"Assets","order":100},"other_current_assets":{"value":3562461000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":3686611000.0,"unit":"USD","label":"Current Assets","order":200}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":4912000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-290000,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":133368000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":133658000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2018-01-01","end_date":"2018-12-31","filing_date":"2019-02-13","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2018","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-19-000006","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-19-000006/files/vrtx-20181231.xml","financials":{"balance_sheet":{"noncurrent_liabilities":{"value":690403000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"prepaid_expenses":{"value":74045000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"other_current_liabilities":{"value":884552000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":6245898000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"wages":{"value":124753000.0,"unit":"USD","label":"Wages","order":730},"liabilities":{"value":1810695000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":2402789000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":124360000.0,"unit":"USD","label":"Inventory","order":230},"equity":{"value":4435203000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":1590784000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":3644704000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":1120292000.0,"unit":"USD","label":"Current Liabilities","order":700},"fixed_assets":{"value":812005000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":4435203000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":3843109000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":6245898000.0,"unit":"USD","label":"Assets","order":100},"accounts_payable":{"value":110987000.0,"unit":"USD","label":"Accounts Payable","order":710}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":1002000.0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"research_and_development":{"value":1416476000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_parent":{"value":2096896000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":2002908000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":600241000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"revenues":{"value":3047597000.0,"unit":"USD","label":"Revenues","order":100},"preferred_stock_dividends_and_other_adjustments":{"value":501000,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":501000,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"cost_of_revenue":{"value":409539000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":259185000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_average_shares":{"value":254292000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":8.24,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_income_loss":{"value":635150000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":-1486862000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"costs_and_expenses":{"value":2412447000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_earnings_per_share":{"value":8.09,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_from_continuing_operations_before_tax":{"value":600241000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":557616000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit_deferred":{"value":-1512252000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_loss_from_continuing_operations_after_tax":{"value":2087103000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":2096395000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"other_operating_expenses":{"value":28816000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"benefits_costs_expenses":{"value":2447356000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":2087103000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"gross_profit":{"value":2638058000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":-9793000.0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit_current":{"value":25390000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-202158000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-202158000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":1270286000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":-71219000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":-6182000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-71219000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":990727000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":1270286000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":996909000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":2133247000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":36351000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":-9793000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":2123454000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2019-01-01","end_date":"2019-03-31","filing_date":"2019-05-01","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2019","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-19-000019","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-19-000019/files/vrtx-20190331.xml","financials":{"income_statement":{"selling_general_and_administrative_expenses":{"value":147045000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":581627000.0,"unit":"USD","label":"Costs And Expenses","order":600},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_income_loss":{"value":276808000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_after_tax":{"value":268631000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":95092000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":486535000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":260175000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":51534000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_available_to_common_stockholders_basic":{"value":268631000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_before_equity_method_investments":{"value":320165000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_parent":{"value":268631000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_before_tax":{"value":320165000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"benefits_costs_expenses":{"value":538270000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_income_expense_after_provision_for_losses":{"value":-14868000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"interest_income_expense_operating_net":{"value":-14868000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"interest_expense_operating":{"value":14868000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"gross_profit":{"value":763343000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_earnings_per_share":{"value":1.05,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"research_and_development":{"value":339490000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":255695000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss":{"value":268631000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_earnings_per_share":{"value":1.03,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"revenues":{"value":858435000.0,"unit":"USD","label":"Revenues","order":100}},"balance_sheet":{"liabilities_and_equity":{"value":6543114000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":4046341000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities":{"value":1819801000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":6543114000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":4723313000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":82262000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":1106468000.0,"unit":"USD","label":"Current Liabilities","order":700},"fixed_assets":{"value":742559000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":1024206000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":4183039000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":2360075000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity":{"value":4723313000.0,"unit":"USD","label":"Equity","order":1400},"inventory":{"value":136698000.0,"unit":"USD","label":"Inventory","order":230},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_noncurrent_assets":{"value":1617516000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":324784000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":243279000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":-41989000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":243657000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":-378000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":324784000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-39138000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-41989000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-39138000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss":{"value":273972000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":273972000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":5341000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2019-04-01","end_date":"2019-06-30","filing_date":"2019-08-01","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2019","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-19-000037","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-19-000037/files/a2019q210-q_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-13015000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":-430000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-50190000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-13015000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":463749000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-50190000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":463749000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":400114000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":400544000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":267427000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"benefits_costs_expenses":{"value":614155000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"selling_general_and_administrative_expenses":{"value":156502000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":267427000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_expense_operating":{"value":14837000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"diluted_earnings_per_share":{"value":1.03,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"interest_income_expense_operating_net":{"value":-14837000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"revenues":{"value":941293000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_before_tax":{"value":327138000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":1.04,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_parent":{"value":267427000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_before_equity_method_investments":{"value":327138000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"interest_income_expense_after_provision_for_losses":{"value":-14837000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"operating_income_loss":{"value":269960000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":59711000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_average_shares":{"value":259822000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_after_tax":{"value":267427000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"costs_and_expenses":{"value":671333000.0,"unit":"USD","label":"Costs And Expenses","order":600},"research_and_development":{"value":379091000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":135740000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_expenses":{"value":535593000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":805553000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"basic_average_shares":{"value":256154000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"balance_sheet":{"equity":{"value":5069965000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":4710968000.0,"unit":"USD","label":"Current Assets","order":200},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"assets":{"value":7033471000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1963506000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":731131000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":143017000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":1182175000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":1259220000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":1591372000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":5069965000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":2322503000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":77045000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities_and_equity":{"value":7033471000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":4567951000.0,"unit":"USD","label":"Other Current Assets","order":250}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":-9201000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":258226000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":258226000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2019-07-01","end_date":"2019-09-30","filing_date":"2019-10-31","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2019","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-19-000057","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-19-000057/files/a2019q310-q_htm.xml","financials":{"balance_sheet":{"equity_attributable_to_parent":{"value":5253394000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":872265000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":7514553000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_assets":{"value":2737459000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":1388894000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":2003950000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"equity":{"value":5253394000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"accounts_payable":{"value":92528000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities":{"value":2261159000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":1296366000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":7514553000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":4614788000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":733509000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":162306000.0,"unit":"USD","label":"Inventory","order":230},"current_assets":{"value":4777094000.0,"unit":"USD","label":"Current Assets","order":200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":79566000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":79566000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":22048000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":20356000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":102945000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-248999000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":-3201000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":106146000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-248999000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":20356000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":334789000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":334789000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"income_statement":{"basic_average_shares":{"value":256946000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":0.22,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":879162000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":260473000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_before_equity_method_investments":{"value":70666000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":99333000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"interest_income_expense_operating_net":{"value":-14548000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"basic_earnings_per_share":{"value":0.22,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue":{"value":131914000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"interest_income_expense_after_provision_for_losses":{"value":-14548000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"net_income_loss_attributable_to_parent":{"value":57518000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"costs_and_expenses":{"value":850495000.0,"unit":"USD","label":"Costs And Expenses","order":600},"interest_expense_operating":{"value":14548000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss":{"value":57518000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":159674000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_before_tax":{"value":70666000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":57518000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":718581000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":817914000.0,"unit":"USD","label":"Gross Profit","order":800},"other_operating_expenses":{"value":2959000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"income_loss_from_continuing_operations_after_tax":{"value":57518000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_tax_expense_benefit":{"value":13148000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"revenues":{"value":949828000.0,"unit":"USD","label":"Revenues","order":100},"research_and_development":{"value":555948000.0,"unit":"USD","label":"Research and Development","order":1030}}}},{"start_date":"2019-01-01","end_date":"2019-12-31","filing_date":"2020-02-13","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2019","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-20-000007","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-20-000007/files/a201910k-main_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":1569330000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"exchange_gains_losses":{"value":1643000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities_continuing":{"value":-1235318000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":126773000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":1569330000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":460785000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":462428000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":126773000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-1235318000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"income_statement":{"income_loss_before_equity_method_investments":{"value":1394919000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_expenses":{"value":2417497000.0,"unit":"USD","label":"Operating Expenses","order":1000},"research_and_development":{"value":1754540000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_from_continuing_operations_after_tax":{"value":1176810000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit_current":{"value":50722000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"costs_and_expenses":{"value":2965255000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_average_shares":{"value":260673000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":1176810000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_available_to_common_stockholders_basic":{"value":1176810000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"selling_general_and_administrative_expenses":{"value":658498000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":3615063000.0,"unit":"USD","label":"Gross Profit","order":800},"income_tax_expense_benefit":{"value":218109000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_average_shares":{"value":256728000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit_deferred":{"value":167387000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":2767902000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_before_tax":{"value":1394919000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":58502000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"other_operating_expenses":{"value":4459000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"basic_earnings_per_share":{"value":4.58,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_income_loss":{"value":1197566000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue":{"value":547758000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"revenues":{"value":4162821000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":1176810000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":4.51,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"balance_sheet":{"equity":{"value":6085244000.0,"unit":"USD","label":"Equity","order":1400},"inventory":{"value":167502000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":898394000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":6085244000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":87610000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":1087753000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"wages":{"value":159464000.0,"unit":"USD","label":"Wages","order":730},"other_current_assets":{"value":4655327000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":3095636000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":3495636000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":8318465000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"assets":{"value":8318465000.0,"unit":"USD","label":"Assets","order":100},"current_liabilities":{"value":1334827000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":2233221000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":4822829000.0,"unit":"USD","label":"Current Assets","order":200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-2632000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":1174178000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":1174178000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2020-01-01","end_date":"2020-03-31","filing_date":"2020-05-01","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2020","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-20-000019","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-20-000019/files/a2020q110-q_htm.xml","financials":{"balance_sheet":{"current_assets":{"value":5446400000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":1438047000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":1538750000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":2431547000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity":{"value":6461654000.0,"unit":"USD","label":"Equity","order":1400},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"noncurrent_assets":{"value":3446801000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":100703000.0,"unit":"USD","label":"Accounts Payable","order":710},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_assets":{"value":5259313000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities_and_equity":{"value":8893201000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_parent":{"value":6461654000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"fixed_assets":{"value":736303000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":2310498000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"assets":{"value":8893201000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":187087000.0,"unit":"USD","label":"Inventory","order":230}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":618109000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":602753000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":15356000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":31666000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":815698000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":481283000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-359430000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":-6651000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-359430000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":31666000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":815698000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":487934000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"diluted_average_shares":{"value":263515000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":54781000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"interest_income_expense_operating_net":{"value":-14136000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"interest_expense_operating":{"value":14136000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"interest_income_expense_after_provision_for_losses":{"value":-14136000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"diluted_earnings_per_share":{"value":2.29,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":2.32,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"basic_average_shares":{"value":259815000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"gross_profit":{"value":1352610000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_parent":{"value":602753000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":602753000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":1515107000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_before_equity_method_investments":{"value":657534000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"research_and_development":{"value":448528000.0,"unit":"USD","label":"Research and Development","order":1030},"benefits_costs_expenses":{"value":857573000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":602753000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":632386000.0,"unit":"USD","label":"Operating Expenses","order":1000},"cost_of_revenue":{"value":162497000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"other_operating_expenses":{"value":1600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"costs_and_expenses":{"value":794883000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss":{"value":602753000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":182258000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":657534000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_income_loss":{"value":720224000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}}}},{"start_date":"2020-04-01","end_date":"2020-06-30","filing_date":"2020-07-31","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2020","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-20-000030","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-20-000030/files/vrtx-20200630_htm.xml","financials":{"income_statement":{"basic_earnings_per_share":{"value":3.22,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"benefits_costs_expenses":{"value":699715000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_expense_operating":{"value":13871000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_available_to_common_stockholders_basic":{"value":837270000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":420928000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_before_equity_method_investments":{"value":824770000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_average_shares":{"value":263403000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":806452000.0,"unit":"USD","label":"Costs And Expenses","order":600},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"net_income_loss_attributable_to_parent":{"value":837270000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":1339965000.0,"unit":"USD","label":"Gross Profit","order":800},"other_operating_expenses":{"value":9200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"revenues":{"value":1524485000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":621932000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":837270000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_income_loss":{"value":718033000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":-12500000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":837270000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_income_expense_after_provision_for_losses":{"value":-13871000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"cost_of_revenue":{"value":184520000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"selling_general_and_administrative_expenses":{"value":191804000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_operating_net":{"value":-13871000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"income_loss_from_continuing_operations_before_tax":{"value":824770000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit_deferred":{"value":-209000000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"basic_average_shares":{"value":259637000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":3.18,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":809766000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":837270000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss_attributable_to_parent":{"value":-27504000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":71912000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":120025000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"exchange_gains_losses":{"value":3272000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":1230464000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":120025000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":71912000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":1233736000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":1038527000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":1038527000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"balance_sheet":{"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":728357000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":2393690000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":2697125000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":1697189000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_current_assets":{"value":6475102000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":6694320000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":219218000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":7519242000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":10216367000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_assets":{"value":3522047000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"accounts_payable":{"value":101451000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":1798640000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":10216367000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity":{"value":7519242000.0,"unit":"USD","label":"Equity","order":1400}}}},{"start_date":"2020-07-01","end_date":"2020-09-30","filing_date":"2020-10-30","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2020","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-20-000043","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-20-000043/files/vrtx-20200930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-140684000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-247937000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-140684000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-247937000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":6158000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":907748000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":519127000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":907748000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":525285000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":640573000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":667434000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss_attributable_to_parent":{"value":-26861000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}},"balance_sheet":{"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"equity_attributable_to_parent":{"value":8133473000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"inventory":{"value":245460000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":3168160000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":2004026000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":3843177000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":11301633000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":11301633000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_liabilities":{"value":1896240000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_liabilities":{"value":1164134000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":7212996000.0,"unit":"USD","label":"Other Current Assets","order":250},"fixed_assets":{"value":920913000.0,"unit":"USD","label":"Fixed Assets","order":320},"accounts_payable":{"value":107786000.0,"unit":"USD","label":"Accounts Payable","order":710},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":8133473000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":7458456000.0,"unit":"USD","label":"Current Assets","order":200},"other_noncurrent_assets":{"value":2522264000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"income_statement":{"diluted_average_shares":{"value":264079000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_earnings_per_share":{"value":2.56,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_available_to_common_stockholders_basic":{"value":667434000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_parent":{"value":667434000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_income_loss":{"value":672241000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"research_and_development":{"value":493497000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":260392000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss":{"value":667434000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_before_tax":{"value":745871000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":1800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_after_tax":{"value":667434000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":78437000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"interest_expense_operating":{"value":13856000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"cost_of_revenue":{"value":186182000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"costs_and_expenses":{"value":866030000.0,"unit":"USD","label":"Costs And Expenses","order":600},"gross_profit":{"value":1352089000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_expenses":{"value":679848000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":745871000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"diluted_earnings_per_share":{"value":2.53,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":792400000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_income_expense_after_provision_for_losses":{"value":-13856000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"selling_general_and_administrative_expenses":{"value":184551000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":1538271000.0,"unit":"USD","label":"Revenues","order":100},"interest_income_expense_operating_net":{"value":-13856000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900}}}},{"start_date":"2020-01-01","end_date":"2020-12-31","filing_date":"2021-02-11","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2020","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-21-000006","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-21-000006/files/vrtx-20201231_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":3253505000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":20552000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":2847612000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":2868164000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":99388000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-505281000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":3253505000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-505281000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":99388000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":2645140000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-66507000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":2645140000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"other_operating_expenses":{"value":13100000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"undistributed_earnings_loss_allocated_to_participating_securities_basic":{"value":0,"unit":"USD","label":"Undistributed Earnings/Loss Allocated To Participating Securities, Basic","order":4100},"income_loss_before_equity_method_investments":{"value":3116798000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_tax_expense_benefit_deferred":{"value":277341000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":1829537000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss":{"value":2711647000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_expense_operating":{"value":58151000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_after_tax":{"value":2711647000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":736300000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"selling_general_and_administrative_expenses":{"value":770456000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":3116798000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"gross_profit":{"value":5469383000.0,"unit":"USD","label":"Gross Profit","order":800},"revenues":{"value":6205683000.0,"unit":"USD","label":"Revenues","order":100},"diluted_average_shares":{"value":263396000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":405151000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_expenses":{"value":2613093000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_tax_expense_benefit_current":{"value":127810000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"net_income_loss_available_to_common_stockholders_basic":{"value":2711647000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"costs_and_expenses":{"value":3349393000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_income_loss":{"value":2856290000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_parent":{"value":2711647000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":10.29,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":3088885000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":259841000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":10.44,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}},"balance_sheet":{"wages":{"value":169387000.0,"unit":"USD","label":"Wages","order":730},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"noncurrent_liabilities":{"value":1187460000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"accounts_payable":{"value":155139000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":1877533000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":280777000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":1553007000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":8686815000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":8686815000.0,"unit":"USD","label":"Equity","order":1400},"other_current_assets":{"value":7852602000.0,"unit":"USD","label":"Other Current Assets","order":250},"assets":{"value":11751808000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_assets":{"value":3618429000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities":{"value":3064993000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":3218429000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":8133379000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":11751808000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}}}},{"start_date":"2021-01-01","end_date":"2021-03-31","filing_date":"2021-04-30","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2021","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-21-000015","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-21-000015/files/vrtx-20210331_htm.xml","financials":{"balance_sheet":{"assets":{"value":12115059000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":3134805000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":8980254000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":8539307000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":3575752000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":8980254000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"accounts_payable":{"value":127839000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":1944050000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":12115059000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":8240444000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_current_liabilities":{"value":1816211000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":3175752000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"inventory":{"value":298863000.0,"unit":"USD","label":"Inventory","order":230}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":688316000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":688316000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss_attributable_to_parent":{"value":35178000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":688316000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-74309000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-518654000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-74309000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":921055000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":324062000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-518654000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":328092000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":921055000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-4030000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000}},"income_statement":{"net_income_loss_available_to_common_stockholders_basic":{"value":653138000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"interest_income_expense_operating_net":{"value":-15678000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":903345000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":259369000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":2.52,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"gross_profit":{"value":1531976000.0,"unit":"USD","label":"Gross Profit","order":800},"income_loss_from_continuing_operations_after_tax":{"value":653138000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":192329000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_earnings_per_share":{"value":2.49,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":653138000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_income_expense_after_provision_for_losses":{"value":-15678000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"research_and_development":{"value":455973000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_parent":{"value":653138000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"revenues":{"value":1724305000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":644150000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":261916000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_before_tax":{"value":820960000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":192077000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":887826000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_before_equity_method_investments":{"value":820960000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"costs_and_expenses":{"value":836479000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":167822000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}}}},{"start_date":"2021-04-01","end_date":"2021-06-30","filing_date":"2021-07-30","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2021","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-21-000027","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-21-000027/files/vrtx-20210630_htm.xml","financials":{"balance_sheet":{"noncurrent_assets":{"value":3764172000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":8457514000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":9196396000.0,"unit":"USD","label":"Equity","order":1400},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"liabilities":{"value":3025290000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":12221686000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":8135894000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":127534000.0,"unit":"USD","label":"Accounts Payable","order":710},"inventory":{"value":321620000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":3364172000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":9196396000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_current_liabilities":{"value":1708914000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":1836448000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":12221686000.0,"unit":"USD","label":"Assets","order":100}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":33550000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-79641000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":33550000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-79641000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":4019000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":-199767000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":-199767000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":-245858000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":-241839000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"comprehensive_income":{"comprehensive_income_loss":{"value":75067000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":75067000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":8143000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":75067000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"operating_expenses":{"value":1603359000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_available_to_common_stockholders_basic":{"value":66924000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"costs_and_expenses":{"value":1831331000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":1600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_income_loss":{"value":-37961000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss":{"value":66924000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":1407090000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":227972000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"interest_income_expense_operating_net":{"value":-15478000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"basic_earnings_per_share":{"value":0.26,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"gross_profit":{"value":1565398000.0,"unit":"USD","label":"Gross Profit","order":800},"selling_general_and_administrative_expenses":{"value":194669000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_before_equity_method_investments":{"value":-44255000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":-111179000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":0.26,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":1837625000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":261020000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"revenues":{"value":1793370000.0,"unit":"USD","label":"Revenues","order":100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"basic_average_shares":{"value":258988000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":66924000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"interest_income_expense_after_provision_for_losses":{"value":-15478000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"income_loss_from_continuing_operations_before_tax":{"value":-44255000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_parent":{"value":66924000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500}}}},{"start_date":"2021-07-01","end_date":"2021-09-30","filing_date":"2021-11-03","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2021","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-21-000033","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-21-000033/files/vrtx-20210930_htm.xml","financials":{"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"other_operating_expenses":{"value":1200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_earnings_per_share":{"value":3.28,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue":{"value":236512000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":851928000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss":{"value":851928000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_after_tax":{"value":851928000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_average_shares":{"value":259707000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_earnings_per_share":{"value":3.3,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":1082741000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"gross_profit":{"value":1747652000.0,"unit":"USD","label":"Gross Profit","order":800},"research_and_development":{"value":493751000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_expenses":{"value":693140000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"interest_income_expense_operating_net":{"value":-15255000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"revenues":{"value":1984164000.0,"unit":"USD","label":"Revenues","order":100},"interest_income_expense_after_provision_for_losses":{"value":-15255000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"selling_general_and_administrative_expenses":{"value":198189000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":1054512000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":230813000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"costs_and_expenses":{"value":929652000.0,"unit":"USD","label":"Costs And Expenses","order":600},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"benefits_costs_expenses":{"value":901423000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":851928000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_average_shares":{"value":257876000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"cash_flow_statement":{"net_cash_flow":{"value":209145000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-656661000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-52952000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":-8461000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-656661000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":927219000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-52952000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":927219000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":217606000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"liabilities":{"value":3088037000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":3366205000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":8519084000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":3766205000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_liabilities":{"value":1786401000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":12618745000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":333456000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":1173773000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"equity_attributable_to_parent":{"value":9530708000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":1914264000.0,"unit":"USD","label":"Current Liabilities","order":700},"accounts_payable":{"value":127863000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":8852540000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":9530708000.0,"unit":"USD","label":"Equity","order":1400},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"liabilities_and_equity":{"value":12618745000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":888624000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":888624000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":36696000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":888624000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2021-01-01","end_date":"2021-12-31","filing_date":"2022-02-09","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2021","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-22-000007","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-22-000007/files/vrtx-20211231_htm.xml","financials":{"income_statement":{"interest_income_expense_after_provision_for_losses":{"value":-61500000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_before_tax":{"value":2730400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":904200000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"costs_and_expenses":{"value":4792300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"selling_general_and_administrative_expenses":{"value":840100000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_operating_net":{"value":-61500000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"operating_expenses":{"value":3888100000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":2782100000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":9.09,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"basic_average_shares":{"value":257700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":9.01,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit_current":{"value":542900000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"gross_profit":{"value":6670200000.0,"unit":"USD","label":"Gross Profit","order":800},"revenues":{"value":7574400000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit_deferred":{"value":-154600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_parent":{"value":2342100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"diluted_average_shares":{"value":259900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":2342100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":388300000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":2342100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_after_tax":{"value":2342100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"benefits_costs_expenses":{"value":4844000000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"research_and_development":{"value":3051100000.0,"unit":"USD","label":"Research and Development","order":1030}},"balance_sheet":{"equity":{"value":10100000000.0,"unit":"USD","label":"Equity","order":1400},"wages":{"value":191300000.0,"unit":"USD","label":"Wages","order":730},"other_current_assets":{"value":9207500000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":3471900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":1755700000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":353100000.0,"unit":"USD","label":"Inventory","order":230},"liabilities_and_equity":{"value":13432500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_parent":{"value":10100000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":13432500000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":1190500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":3332500000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":2142000000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":3871900000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":9560600000.0,"unit":"USD","label":"Current Assets","order":200},"accounts_payable":{"value":195000000.0,"unit":"USD","label":"Accounts Payable","order":710}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":2426500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":2426500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":2426500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":84400000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}},"cash_flow_statement":{"net_cash_flow":{"value":811200000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-1478000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-340900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":2643500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":2643500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"exchange_gains_losses":{"value":-13400000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-1478000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":824600000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-340900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}}}},{"start_date":"2022-01-01","end_date":"2022-03-31","filing_date":"2022-05-06","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2022","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-22-000014","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-22-000014/files/vrtx-20220331_htm.xml","financials":{"balance_sheet":{"equity":{"value":10907000000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":14256100000.0,"unit":"USD","label":"Assets","order":100},"accounts_payable":{"value":173600000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":10361300000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":2006600000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_noncurrent_assets":{"value":3494800000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"intangible_assets":{"value":400000000.0,"unit":"USD","label":"Intangible Assets","order":330},"liabilities":{"value":3349100000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_parent":{"value":10907000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":3894800000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_current_assets":{"value":10022400000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":338900000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":2180200000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":14256100000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"income_statement":{"gross_profit":{"value":1851700000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_expenses":{"value":810800000.0,"unit":"USD","label":"Operating Expenses","order":1000},"revenues":{"value":2097500000.0,"unit":"USD","label":"Revenues","order":100},"cost_of_revenue":{"value":245800000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"costs_and_expenses":{"value":1056600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"research_and_development":{"value":603100000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":2.96,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":762100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_earnings_per_share":{"value":2.99,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"selling_general_and_administrative_expenses":{"value":215200000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_average_shares":{"value":255100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss":{"value":762100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_income_expense_after_provision_for_losses":{"value":-14900000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"other_operating_expenses":{"value":595600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_after_tax":{"value":762100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_average_shares":{"value":257900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":762100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_tax_expense_benefit":{"value":192700000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_before_tax":{"value":954800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_income_loss":{"value":1040900000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"benefits_costs_expenses":{"value":1142700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_income_expense_operating_net":{"value":-14900000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000}},"cash_flow_statement":{"exchange_gains_losses":{"value":-5900000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-51000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":956200000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":956200000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":803900000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":809800000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":-95400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-51000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-95400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss":{"value":757500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":757500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":-4600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":757500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2022-04-01","end_date":"2022-06-30","filing_date":"2022-08-05","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2022","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-22-000030","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-22-000030/files/vrtx-20220630_htm.xml","financials":{"balance_sheet":{"assets":{"value":15582200000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"intangible_assets":{"value":387000000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_parent":{"value":11933500000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"inventory":{"value":367700000.0,"unit":"USD","label":"Inventory","order":230},"accounts_payable":{"value":198000000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity":{"value":11933500000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":2358200000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":4078700000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":2556200000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":3691700000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":3648700000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":11135800000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":11503500000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":15582200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"cash_flow_statement":{"net_cash_flow":{"value":1100100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":47700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_financing_activities":{"value":47700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":1126000000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-61500000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":1139800000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-61500000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":-25900000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":1139800000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"comprehensive_income":{"comprehensive_income_loss":{"value":856700000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":856700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":856700000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss_attributable_to_parent":{"value":46200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}},"income_statement":{"interest_income_expense_operating_net":{"value":-14600000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"operating_income_loss":{"value":1106300000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"costs_and_expenses":{"value":1089900000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"gross_profit":{"value":1934400000.0,"unit":"USD","label":"Gross Profit","order":800},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"basic_average_shares":{"value":255900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_average_shares":{"value":258700000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"revenues":{"value":2196200000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_before_tax":{"value":1024400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":261800000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"interest_income_expense_after_provision_for_losses":{"value":-14600000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"net_income_loss_attributable_to_parent":{"value":810500000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":810500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_earnings_per_share":{"value":3.17,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":810500000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_available_to_common_stockholders_basic":{"value":810500000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_earnings_per_share":{"value":3.13,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit":{"value":213900000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_expenses":{"value":828100000.0,"unit":"USD","label":"Operating Expenses","order":1000},"benefits_costs_expenses":{"value":1171800000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"other_operating_expenses":{"value":612800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"selling_general_and_administrative_expenses":{"value":215300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010}}}},{"start_date":"2022-07-01","end_date":"2022-09-30","filing_date":"2022-10-28","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2022","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-22-000038","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-22-000038/files/vrtx-20220930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-60200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-384200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-60200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":-38200000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow":{"value":472900000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":511100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":955500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-384200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":955500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"income_statement":{"selling_general_and_administrative_expenses":{"value":246800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_after_provision_for_losses":{"value":-13700000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"income_loss_from_continuing_operations_before_tax":{"value":1176400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":289400000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":930500000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":3.59,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":256500000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_income_loss":{"value":1126700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":2334300000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss":{"value":930500000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":1207600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_after_tax":{"value":930500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_average_shares":{"value":259500000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_earnings_per_share":{"value":3.63,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"interest_income_expense_operating_net":{"value":-13700000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"benefits_costs_expenses":{"value":1157900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":930500000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit":{"value":245900000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"gross_profit":{"value":2044900000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_expenses":{"value":918200000.0,"unit":"USD","label":"Operating Expenses","order":1000},"other_operating_expenses":{"value":671400000.0,"unit":"USD","label":"Other Operating Expenses","order":1040}},"balance_sheet":{"equity":{"value":13029600000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":2482400000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":4435400000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities":{"value":3676800000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":11882800000.0,"unit":"USD","label":"Other Current Assets","order":250},"accounts_payable":{"value":126900000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":12271000000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":2609300000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":16706400000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":16706400000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":13029600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":1067500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"intangible_assets":{"value":603600000.0,"unit":"USD","label":"Intangible Assets","order":330},"inventory":{"value":388200000.0,"unit":"USD","label":"Inventory","order":230},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_noncurrent_assets":{"value":3831800000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":970600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":40100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":970600000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":970600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2022-01-01","end_date":"2022-12-31","filing_date":"2023-02-10","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2022","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-23-000007","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-23-000007/files/vrtx-20221231_htm.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":3306900000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":3306900000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":3306900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":-15100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}},"balance_sheet":{"other_current_assets":{"value":12662400000.0,"unit":"USD","label":"Other Current Assets","order":250},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"current_assets":{"value":13234800000.0,"unit":"USD","label":"Current Assets","order":200},"other_noncurrent_assets":{"value":4312500000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":2191700000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":18150900000.0,"unit":"USD","label":"Assets","order":100},"wages":{"value":246500000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_liabilities":{"value":1496100000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":4238200000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":18150900000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":460600000.0,"unit":"USD","label":"Inventory","order":230},"prepaid_expenses":{"value":111800000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"intangible_assets":{"value":603600000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"accounts_payable":{"value":303900000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":2742100000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":4916100000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":13912700000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":13912700000.0,"unit":"USD","label":"Equity","order":1400}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":4129900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":3741100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":3711900000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":-67700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-321100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-67700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":4129900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"exchange_gains_losses":{"value":-29200000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-321100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue":{"value":1080300000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_tax_expense_benefit_current":{"value":1186300000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"net_income_loss":{"value":3322000000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_parent":{"value":3322000000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"interest_income_expense_operating_net":{"value":-54800000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"selling_general_and_administrative_expenses":{"value":944700000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"operating_income_loss":{"value":4307400000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_before_tax":{"value":4232400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":2598300000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_average_shares":{"value":259100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit_deferred":{"value":-275900000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"revenues":{"value":8930700000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_after_tax":{"value":3322000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":910400000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":12.82,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":256100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"interest_income_expense_after_provision_for_losses":{"value":-54800000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"benefits_costs_expenses":{"value":4698300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_earnings_per_share":{"value":12.97,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_available_to_common_stockholders_basic":{"value":3322000000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":3543000000.0,"unit":"USD","label":"Operating Expenses","order":1000},"costs_and_expenses":{"value":4623300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"gross_profit":{"value":7850400000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900}}}},{"start_date":"2023-01-01","end_date":"2023-03-31","filing_date":"2023-05-02","acceptance_datetime":"2023-05-02T20:07:33Z","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2023","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-23-000012","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-23-000012/files/vrtx-20230331_htm.xml","financials":{"balance_sheet":{"inventory":{"value":535100000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":14432300000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":14432300000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":3026200000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":18974200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":12430600000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"intangible_assets":{"value":603600000.0,"unit":"USD","label":"Intangible Assets","order":330},"assets":{"value":18974200000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":5404900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":12965700000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":2703000000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":6008500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities":{"value":4541900000.0,"unit":"USD","label":"Liabilities","order":600},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"accounts_payable":{"value":323200000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}},"cash_flow_statement":{"net_cash_flow":{"value":-1216400000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":-294700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":899900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-1833600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-1833600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-294700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-1228400000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"exchange_gains_losses":{"value":12000000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities_continuing":{"value":899900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue":{"value":266900000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"benefits_costs_expenses":{"value":1483300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"gross_profit":{"value":2107900000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_available_to_common_stockholders_basic":{"value":699800000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"interest_income_expense_operating_net":{"value":-11400000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_earnings_per_share":{"value":2.72,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"revenues":{"value":2374800000.0,"unit":"USD","label":"Revenues","order":100},"diluted_earnings_per_share":{"value":2.69,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"interest_income_expense_after_provision_for_losses":{"value":-11400000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"costs_and_expenses":{"value":1595800000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":191700000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_after_tax":{"value":699800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_average_shares":{"value":260300000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":699800000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"other_operating_expenses":{"value":1087800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":891500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_expenses":{"value":1328900000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss":{"value":699800000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_income_loss":{"value":779000000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"selling_general_and_administrative_expenses":{"value":241100000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"basic_average_shares":{"value":257400000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":-13900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":685900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":685900000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":685900000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2023-04-01","end_date":"2023-06-30","filing_date":"2023-08-02","acceptance_datetime":"2023-08-02T20:05:15Z","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2023","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-23-000021","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-23-000021/files/vrtx-20230630_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":889000000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":-26700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":889000000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":889000000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_continuing":{"value":847800000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":17300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":10000000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":17300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":1134400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":1134400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-303900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-303900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":857800000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"income_statement":{"income_loss_from_continuing_operations_after_tax":{"value":915700000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_earnings_per_share":{"value":3.55,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":915700000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":260400000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_income_loss":{"value":1026400000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"benefits_costs_expenses":{"value":1331700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"cost_of_revenue":{"value":308600000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_earnings_per_share":{"value":3.52,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_attributable_to_parent":{"value":915700000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":257700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"other_operating_expenses":{"value":895600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"revenues":{"value":2493200000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":262600000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_income_expense_operating_net":{"value":-11200000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"interest_income_expense_after_provision_for_losses":{"value":-11200000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"income_loss_from_continuing_operations_before_tax":{"value":1161500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"gross_profit":{"value":2184600000.0,"unit":"USD","label":"Gross Profit","order":800},"costs_and_expenses":{"value":1466800000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_available_to_common_stockholders_basic":{"value":915700000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":1158200000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_tax_expense_benefit":{"value":245800000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900}},"balance_sheet":{"other_noncurrent_assets":{"value":5872700000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":15470200000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":13872900000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":3352100000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":20349200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"intangible_assets":{"value":603600000.0,"unit":"USD","label":"Intangible Assets","order":330},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":15470200000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_liabilities":{"value":2989100000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities":{"value":4879000000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":603500000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_assets":{"value":6476300000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_current_assets":{"value":13269400000.0,"unit":"USD","label":"Other Current Assets","order":250},"assets":{"value":20349200000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"accounts_payable":{"value":363000000.0,"unit":"USD","label":"Accounts Payable","order":710}}}},{"start_date":"2023-07-01","end_date":"2023-09-30","filing_date":"2023-11-07","acceptance_datetime":"2023-11-07T21:16:57Z","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2023","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-23-000031","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-23-000031/files/vrtx-20230930_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":36800000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":1072100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":1072100000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":1072100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"income_statement":{"basic_average_shares":{"value":258000000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"cost_of_revenue":{"value":318700000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":260600000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"net_income_loss_attributable_to_parent":{"value":1035300000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"interest_income_expense_operating_net":{"value":-10900000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"gross_profit":{"value":2164800000.0,"unit":"USD","label":"Gross Profit","order":800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"benefits_costs_expenses":{"value":1304300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"interest_income_expense_after_provision_for_losses":{"value":-10900000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"other_operating_expenses":{"value":862900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_after_tax":{"value":1035300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_income_loss":{"value":1038100000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":4.01,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_available_to_common_stockholders_basic":{"value":1035300000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_before_tax":{"value":1179200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_expenses":{"value":1126700000.0,"unit":"USD","label":"Operating Expenses","order":1000},"costs_and_expenses":{"value":1445400000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":143900000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"selling_general_and_administrative_expenses":{"value":263800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":2483500000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss":{"value":1035300000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_earnings_per_share":{"value":3.97,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"balance_sheet":{"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"other_current_liabilities":{"value":3223500000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"intangible_assets":{"value":603600000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity":{"value":16512800000.0,"unit":"USD","label":"Equity","order":1400},"liabilities_and_equity":{"value":21726200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":688700000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":3599400000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":14695800000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":1614000000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":21726200000.0,"unit":"USD","label":"Assets","order":100},"other_current_assets":{"value":14007100000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities":{"value":5213400000.0,"unit":"USD","label":"Liabilities","order":600},"accounts_payable":{"value":375900000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_noncurrent_assets":{"value":6426800000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":7030400000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":16512800000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"cash_flow_statement":{"exchange_gains_losses":{"value":-22500000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-165000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":1268400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-117700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-117700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-165000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":985700000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":1268400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":963200000.0,"unit":"USD","label":"Net Cash Flow","order":1100}}}},{"start_date":"2023-01-01","end_date":"2023-12-31","filing_date":"2024-02-15","acceptance_datetime":"2024-02-15T21:12:14Z","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2023","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-24-000062","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-24-000062/files/vrtx-20231231_htm.xml","financials":{"balance_sheet":{"assets":{"value":22730200000.0,"unit":"USD","label":"Assets","order":100},"prepaid_expenses":{"value":108600000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"liabilities_and_equity":{"value":22730200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":17580400000.0,"unit":"USD","label":"Equity","order":1400},"accounts_payable":{"value":364900000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_parent":{"value":17580400000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":1602400000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"wages":{"value":295000000.0,"unit":"USD","label":"Wages","order":730},"other_current_assets":{"value":13296800000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_liabilities":{"value":3547400000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":7746100000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":2887500000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":738800000.0,"unit":"USD","label":"Inventory","order":230},"current_assets":{"value":14144200000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":8586000000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"intangible_assets":{"value":839900000.0,"unit":"USD","label":"Intangible Assets","order":330},"liabilities":{"value":5149800000.0,"unit":"USD","label":"Liabilities","order":600},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-562200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-3141700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":26900000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-562200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":3537300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":-139700000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-3141700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-166600000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":3537300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"income_statement":{"cost_of_revenue":{"value":1262200000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"interest_income_expense_after_provision_for_losses":{"value":-44100000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"diluted_earnings_per_share":{"value":13.89,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":3619600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"revenues":{"value":9869200000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":1136600000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_after_tax":{"value":3619600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_average_shares":{"value":257700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_before_tax":{"value":4379800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss":{"value":3619600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit_deferred":{"value":-536500000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"interest_income_expense_operating_net":{"value":-44100000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"operating_income_loss":{"value":3832000000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":4775000000.0,"unit":"USD","label":"Operating Expenses","order":1000},"costs_and_expenses":{"value":6037200000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":760200000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"diluted_average_shares":{"value":260500000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"benefits_costs_expenses":{"value":5489400000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"other_operating_expenses":{"value":3638400000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit_current":{"value":1296700000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"net_income_loss_attributable_to_parent":{"value":3619600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":8607000000.0,"unit":"USD","label":"Gross Profit","order":800},"basic_earnings_per_share":{"value":14.05,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}},"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":-15100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":3604500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":3604500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":3604500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2024-01-01","end_date":"2024-03-31","filing_date":"2024-05-07","acceptance_datetime":"2024-05-07T20:14:28Z","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2024","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-24-000139","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-24-000139/files/vrtx-20240331_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_continuing":{"value":-1187300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":-1202900000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":1306600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":1306600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-357500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-2136400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"exchange_gains_losses":{"value":-15600000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-2136400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-357500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"balance_sheet":{"other_current_liabilities":{"value":3444500000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_liabilities":{"value":3795900000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":813100000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":5370800000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":23917400000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":18546600000.0,"unit":"USD","label":"Equity","order":1400},"accounts_payable":{"value":351400000.0,"unit":"USD","label":"Accounts Payable","order":710},"intangible_assets":{"value":834900000.0,"unit":"USD","label":"Intangible Assets","order":330},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":23917400000.0,"unit":"USD","label":"Assets","order":100},"current_assets":{"value":13288700000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":12475600000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":10628700000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":18546600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_noncurrent_assets":{"value":9793800000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"income_statement":{"diluted_average_shares":{"value":261100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":1099600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue":{"value":342600000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"interest_income_expense_after_provision_for_losses":{"value":-10400000.0,"unit":"USD","label":"Interest Income/Expense After Provision For Losses","order":2800},"basic_earnings_per_share":{"value":4.26,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"benefits_costs_expenses":{"value":1411500000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"provision_for_loan_lease_and_other_losses":{"value":0,"unit":"USD","label":"Provision For Loan, Lease, And Other Losses","order":4000},"income_loss_from_continuing_operations_after_tax":{"value":1099600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":2690600000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":1139500000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_parent":{"value":1099600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_expenses":{"value":1208500000.0,"unit":"USD","label":"Operating Expenses","order":1000},"selling_general_and_administrative_expenses":{"value":342700000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_available_to_common_stockholders_basic":{"value":1099600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_average_shares":{"value":258200000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_before_tax":{"value":1279100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit":{"value":179500000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"other_operating_expenses":{"value":865800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"gross_profit":{"value":2348000000.0,"unit":"USD","label":"Gross Profit","order":800},"costs_and_expenses":{"value":1551100000.0,"unit":"USD","label":"Costs And Expenses","order":600},"interest_income_expense_operating_net":{"value":-10400000.0,"unit":"USD","label":"Interest Income/Expense Operating, Net","order":2900},"diluted_earnings_per_share":{"value":4.21,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":31600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":1131200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":1131200000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":1131200000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2024-04-01","end_date":"2024-06-30","filing_date":"2024-08-02","acceptance_datetime":"2024-08-02T20:03:02Z","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2024","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-24-000198","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-24-000198/files/vrtx-20240630_htm.xml","financials":{"balance_sheet":{"other_current_assets":{"value":8027000000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_parent":{"value":14774700000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"noncurrent_assets":{"value":11190500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":327900000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":10353000000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":8941600000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":20132100000.0,"unit":"USD","label":"Assets","order":100},"intangible_assets":{"value":837500000.0,"unit":"USD","label":"Intangible Assets","order":330},"current_liabilities":{"value":3547200000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":5357400000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":3219300000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":914600000.0,"unit":"USD","label":"Inventory","order":230},"liabilities_and_equity":{"value":20132100000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":14774700000.0,"unit":"USD","label":"Equity","order":1400}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":5200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":-3588400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-3588400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":-3588400000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow":{"value":-4578400000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-4575900000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":-3753600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-463700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-358600000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":-3753600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":-2500000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_investing_activities":{"value":-463700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-358600000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"income_statement":{"basic_average_shares":{"value":258100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"benefits_costs_expenses":{"value":6036800000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":-3391200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_from_continuing_operations_after_tax":{"value":-3593600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":6160300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":5416200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit":{"value":202400000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":-3593600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_expenses":{"value":5788400000.0,"unit":"USD","label":"Operating Expenses","order":1000},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue":{"value":371900000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_income_loss":{"value":-3514700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_average_shares":{"value":258100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"selling_general_and_administrative_expenses":{"value":372200000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":2273700000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_earnings_per_share":{"value":-13.92,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"revenues":{"value":2645600000.0,"unit":"USD","label":"Revenues","order":100},"basic_earnings_per_share":{"value":-13.92,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_parent":{"value":-3593600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_available_to_common_stockholders_basic":{"value":-3593600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}}}},{"start_date":"2024-07-01","end_date":"2024-09-30","filing_date":"2024-11-05","acceptance_datetime":"2024-11-05T21:11:53Z","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2024","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-24-000223","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-24-000223/files/vrtx-20240930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":1369800000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":-387500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":657100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-348000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":22800000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-387500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-348000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":1369800000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":634300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"net_income_loss_available_to_common_stockholders_basic":{"value":1045400000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":1263000000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":258000000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_parent":{"value":1045400000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":1045400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"costs_and_expenses":{"value":1655600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss":{"value":1045400000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"basic_earnings_per_share":{"value":4.05,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"selling_general_and_administrative_expenses":{"value":371800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":1116300000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":261000000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":1547800000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"gross_profit":{"value":2379300000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue":{"value":392600000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"revenues":{"value":2771900000.0,"unit":"USD","label":"Revenues","order":100},"diluted_earnings_per_share":{"value":4.01,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"other_operating_expenses":{"value":891200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":1224100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit":{"value":178700000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"balance_sheet":{"other_current_liabilities":{"value":3577300000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"intangible_assets":{"value":831600000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_parent":{"value":15630900000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":9804100000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":22240200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":3973100000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":6609300000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":1079800000.0,"unit":"USD","label":"Inventory","order":230},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"accounts_payable":{"value":395800000.0,"unit":"USD","label":"Accounts Payable","order":710},"assets":{"value":22240200000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":2636200000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity":{"value":15630900000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":12436100000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":8724300000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":11604500000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}},"comprehensive_income":{"comprehensive_income_loss":{"value":1051700000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":1051700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":6300000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":1051700000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2024-01-01","end_date":"2024-12-31","filing_date":"2025-02-13","acceptance_datetime":"2025-02-13T21:01:52Z","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2024","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-25-000053","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-25-000053/files/vrtx-20241231_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow":{"value":-5800100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"exchange_gains_losses":{"value":-42600000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":-492600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":-492600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-3770000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-1494900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-5757500000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-3770000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-1494900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}},"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":142100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":-393500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-393500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":-393500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"benefits_costs_expenses":{"value":10771600000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":248500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"other_operating_expenses":{"value":8258200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"revenues":{"value":11020100000.0,"unit":"USD","label":"Revenues","order":100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":-2.08,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_parent":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":257900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"selling_general_and_administrative_expenses":{"value":1464300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit":{"value":784100000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit_current":{"value":1132900000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"gross_profit":{"value":9489600000.0,"unit":"USD","label":"Gross Profit","order":800},"income_tax_expense_benefit_deferred":{"value":-348800000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"diluted_average_shares":{"value":257900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"diluted_earnings_per_share":{"value":-2.08,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue":{"value":1530500000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"costs_and_expenses":{"value":11253000000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_from_continuing_operations_after_tax":{"value":-535600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_income_loss":{"value":-232900000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":9722500000.0,"unit":"USD","label":"Operating Expenses","order":1000}},"balance_sheet":{"intangible_assets":{"value":825900000.0,"unit":"USD","label":"Intangible Assets","order":330},"inventory":{"value":1205400000.0,"unit":"USD","label":"Inventory","order":230},"current_assets":{"value":9596400000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities":{"value":6123600000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":2799500000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":16409600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":12936800000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"assets":{"value":22533200000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":16409600000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":2559000000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_noncurrent_assets":{"value":12110900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"prepaid_expenses":{"value":102200000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"wages":{"value":352100000.0,"unit":"USD","label":"Wages","order":730},"current_liabilities":{"value":3564600000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":8288800000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":22533200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"accounts_payable":{"value":413000000.0,"unit":"USD","label":"Accounts Payable","order":710}}}},{"start_date":"2024-01-01","end_date":"2024-12-31","filing_date":"2025-02-13","acceptance_datetime":"2025-02-13T21:01:52Z","timeframe":"ttm","fiscal_period":"TTM","fiscal_year":"2024","cik":"0000875320","sic":"2834","tickers":["VRTX"],"company_name":"VERTEX PHARMACEUTICALS INC / MA","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0000875320-25-000053","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0000875320-25-000053/files/vrtx-20241231_htm.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":-393500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss_attributable_to_parent":{"value":142100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"other_comprehensive_income_loss":{"value":-393500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-393500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"balance_sheet":{"wages":{"value":352100000.0,"unit":"USD","label":"Wages","order":730},"liabilities_and_equity":{"value":22533200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":12936800000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":3564600000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":12110900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":2559000000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":413000000.0,"unit":"USD","label":"Accounts Payable","order":710},"commitments_and_contingencies":{"value":0,"unit":"USD","label":"Commitments and Contingencies","order":900},"current_assets":{"value":9596400000.0,"unit":"USD","label":"Current Assets","order":200},"intangible_assets":{"value":825900000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_parent":{"value":16409600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":6123600000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":2799500000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":1205400000.0,"unit":"USD","label":"Inventory","order":230},"prepaid_expenses":{"value":102200000.0,"unit":"USD","label":"Prepaid Expenses","order":240},"assets":{"value":22533200000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":16409600000.0,"unit":"USD","label":"Equity","order":1400},"other_current_assets":{"value":8288800000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}},"income_statement":{"other_operating_expenses":{"value":8258200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"gross_profit":{"value":9489600000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue":{"value":1530500000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_after_tax":{"value":-535600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"benefits_costs_expenses":{"value":10771600000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"operating_income_loss":{"value":-232900000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_average_shares":{"value":257900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_before_tax":{"value":248500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":-2.08,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_expenses":{"value":9722500000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":257900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit_current":{"value":1132900000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":784100000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_parent":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":-535600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"selling_general_and_administrative_expenses":{"value":1464300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":11253000000.0,"unit":"USD","label":"Costs And Expenses","order":600},"revenues":{"value":11020100000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit_deferred":{"value":-348800000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"diluted_earnings_per_share":{"value":-2.08,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-1494900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":-42600000.0,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-1494900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-3770000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":-5800100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":-492600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-3770000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":-492600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":-5757500000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}}}}],"status":"OK","request_id":"b2caca0454f7c13be3bf9a131e2283b3"}
